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Thesis Portfolio Abstract 
 
The psychological impact that food allergy may have for both children and their 
parents has received increased interest in recent years. This portfolio aims to offer a 
timely and novel contribution to this field, through firstly presenting a systematic 
review with meta-analysis assessing the prevalence of anxiety, depression, and post-
traumatic stress in children with food allergy. An original piece of empirical research 
is subsequently presented, assessing worry, anxiety, and post-traumatic stress 
symptoms in a relatively large sample (N=104-105) of parents of children with food 
allergy. 
The systematic review found pooled prevalence estimates of 12.6% (95% CIs 
6.0%-19.3%) for anxiety and 6.9% (95% CIs 1.3%-12.5%) for depression in children 
with food allergy. Compared to their peers without food allergy, the review found a 
small but significant increase in anxiety (d=0.21; 95% CIs 0.16-0.26) and depression 
(d=0.30; 95% CIs 0.14-0.45) in children with food allergy. However, due to high 
degrees of heterogeneity and relatively small sample sizes, these results remain 
tentative. Additionally, only one pilot study was found assessing post-traumatic 
stress. 
The empirical study used an online questionnaire to assess mental health in 
parents of children with food allergy. The study found 81.0% of parents reported 
clinically significant worry, 42.3% met the clinical cut-off for post-traumatic stress 
symptoms, and 39.1% reported moderate-extremely severe anxiety. Regression 
analyses were conducted including allergy severity, intolerance of uncertainty, and 
food allergy self-efficacy, which were significant for all three psychological 
outcomes. However, intolerance of uncertainty was the most consistent predictor of 
poorer mental health. 
Overall, the portfolio highlights the need for further consideration of the 
psychological impact of food allergy. In particular, the potential for post-traumatic 
stress in this population, which had not previously been assessed in a large-scale 
study. Theoretical and clinical implications, as well as recommendations for future 
research are discussed. 
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Introduction to Portfolio 
 
Food allergy is a relatively common chronic health condition in childhood, with 
prevalence around 6-8%, and suggestions of rising prevalence over recent years 
(Luyt, Ball, Kirk, & Stiefel, 2016). Food allergy also presents some largely unique 
challenges for children and those caring for children with food allergy. Medical 
management of food allergy currently focuses on reducing the risk of exposure (i.e. 
avoiding allergens) and managing symptoms where accidental exposure occurs 
(Boyce et al., 2011). As well as being a necessity, food is often social and, albeit to 
varying degrees, dependent on others (e.g. shops/food suppliers), which is a notable 
difference to most other forms of allergy (e.g. venom). Successful avoidance can 
therefore be challenging, and relies on the understanding and caution of not only 
themselves but also other individuals (e.g. teachers, those working in the food 
industry) and large food companies (i.e. for accurate allergen labeling).  
Over recent years, there has been an increased awareness of the possible 
impact food allergy could have for the psychological wellbeing of children and their 
parents/carers (e.g. Cummings, Knibb, King, & Lucas, 2010). However, as the field 
remains in its relative infancy, there are substantial gaps in the psychological 
literature. This portfolio aims to offer a timely contribution to this field: firstly, 
offering a systematic review of the current evidence base assessing the prevalence of 
mental health problems in children with food allergy; secondly, presenting an 
original piece of empirical research that assesses anxiety and post-traumatic stress 
symptoms in parents of children with food allergy. Additional information on the 
methodology and results of the empirical paper is also provided, and the thesis 
concludes with a summary and discussion of the results and implications of the 
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portfolio. However, it is first useful to provide an overview of information and 
terminology relevant to the remainder of this portfolio: firstly through outlining how 
‘children’ is defined within this portfolio; and secondly defining food allergy, and 
overviewing allergy symptoms and management.  
The age range to which ‘children’ refers is variable across the literature. For 
example, in some instances ‘children’ is used to refer to the pre-adolescence period 
ending around the age of 12 years (e.g. Hardin & Hackell, 2017). This portfolio takes 
a wider definition of ‘children’ referring to the period between birth and adulthood, 
which is in keeping with legal definitions (e.g. United Nations, 1989) and much of 
the paediatric psychology literature (e.g. Bennett, Shafran, Coughtrey, Walker, & 
Heyman, 2015; Lau et al., 2014; Roberts, Maddux, & Wright, 1984). The age at 
which ‘adulthood’ is considered to begin is variable, but often refers to a time 
between the ages of 16 and 19 years (e.g. European Union Agency for Fundamental 
Rights, 2017; World Health Organisation, 2013).  As the systematic review within 
this portfolio aims to synthesise the wider literature, an internationally relevant 
definition of children from the United Nations is used, which defines a child as 
someone below the age of 18 years (United Nations, 1989).  In contrast, the 
empirical paper is limited to the United Kingdom (UK). Whilst the legal definition of 
a child in the UK is below 18 years (Children Act 1989), the paediatric service where 
recruitment occurred, and many health services, transition children to adult care at 17 
years. As such, the slightly younger age range of 0-16 years is used for the purpose 
of the empirical paper within this portfolio. 
Food allergies involve adverse immune reactions to specific allergens, with 
symptoms affecting the skin, respiratory and/or gastrointestinal systems (NICE, 
2011a). Food allergies can be broadly categorized as immunoglobulin E (IgE)-
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mediated and non-IgE mediated. IgE-mediated allergies are typically characterized 
by rapid reactions and can in the most severe instances lead to anaphylaxis. 
Anaphylaxis is a potentially life threatening reaction, involving rapid changes to 
breathing, airways, and/or circulation (Resuscitation Council (UK), 2008). Non-IgE 
mediated allergies typically involve delayed reactions and symptoms such as 
eczema, diarrhea or constipation (NICE, 2011a). However, mixed IgE and non-IgE 
reactions are possible. 
Diagnosis of food allergy involves taking a clinical history. Where IgE-
mediated allergy is suspected, blood tests and/or skin prick tests should be used to 
aid diagnosis, whereas suspected non-IgE allergies typically involve trial elimination 
and reintroduction of the suspected allergen (NICE, 2011a).  
If exposure to food allergen(s) occurs, for milder allergic reactions, 
management of symptoms typically involves the use of anti-histamines (Boyce et al., 
2011). Where anaphylaxis is suspected, the focus is on administering epinephrine at 
the earliest possible opportunity (Boyce et al., 2011); as such, individuals at risk of 
anaphylaxis should carry an adrenaline auto injector (AAI; e.g. EpiPen, Emerade). If 
anaphylaxis is suspected, emergency services should be contacted and children 
suspected of experiencing anaphylaxis should be admitted to hospital under the care 
of a paediatric medical team (NICE, 2011b). 
Overall, children with food allergy and their parents face a number of 
additional challenges and risks, which is important context for understanding 
psychological wellbeing in this population, as discussed throughout the remaining 
portfolio. The following chapter presents a systematic review with meta-analysis 
assessing the prevalence of mental health conditions in children with food allergy. 
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Chapter 1: Systematic Review 
 
 
The following paper has been written in accordance with the guidelines of the 
journal Allergy. Author guidelines for Allergy are displayed in Appendix A. For the 
purpose of the thesis portfolio, tables and figures have been included in position. 
Information that would be submitted as supplementary material is indicated in text 
and included immediately following the paper. Forest plots included for the purpose 
of the thesis portfolio only are displayed in Appendix B.  
 
Word count (UEA guidelines): 4998 
_________________ 
 
 
What is the prevalence of anxiety, depression, and post-traumatic stress in 
children with food allergies? A meta-analysis. 
 
Short title: Mental health in paediatric food allergy: A review 
Authors: Kate Roberts1, Richard Meiser-Stedman1, Judith Young1 
Affiliation: 1Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ 
Acknowledgements: With thanks to Hannah Edwards (Leeds and York Partnership 
NHS Foundation Trust) for acting as a second full text reviewer and Hannah Crook 
(University of East Anglia) for acting as a second quality assessment reviewer. 
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Abstract 
Introduction: Paediatric food allergy has been suggested to impact on children’s 
psychological wellbeing. This review evaluates the prevalence of anxiety, 
depression, and post-traumatic stress in children (aged 0-17 years) with food allergy, 
and compares this to children without food allergy. Method: A systematic search of 
three databases (Medline, CINAHL and PsycINFO) found 14 studies that met the 
review inclusion criteria. Risk of bias was assessed, and where sufficient data was 
available random effects meta-analyses were used to synthesise the data. Results: 
The review found pooled prevalence estimates of 12.6% (95% CIs 6.0%-19.3%) for 
anxiety and 6.9% (95% CIs 1.3%-12.5%) for depression in children with food 
allergy. Compared to their peers without food allergy, the review found a small but 
significant increase in anxiety (d=0.21; 95% CIs 0.16-0.26) and depression (d=0.30; 
95% CIs 0.14-0.45) in children with food allergy. However, these results differed 
between anxiety disorders, with evidence of increased separation and generalized 
anxiety but no significant increase in social anxiety in children with food allergy. 
Only one pilot study was identified assessing post-traumatic stress in children with 
food allergy. Conclusion: This review indicates that children with food allergy may 
be at a small but significant increased risk of experiencing mental health problems. 
However, there is a high degree of heterogeneity in the current evidence base, and 
the total sample sizes remain small, therefore the conclusions drawn are tentative.  
 
Key words: anxiety, depression, food allergy, post-traumatic stress, review 
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Introduction 
It has been suggested that children with chronic health conditions may be at greater 
risk of experiencing mental health problems, for example due to needing to manage 
symptoms of illness and medical procedures.1 Meta-analyses support an overall small 
increase in anxiety and depression in children with chronic health conditions.1,2 
However, substantial variance in the effect sizes between health conditions was 
found, demonstrating the importance of considering mental health in specific health 
problems rather than general paediatric populations. Food allergy was not included in 
these previous reviews, despite being a common health condition in childhood,3 
likely due to the paucity of available research at the time.  
Food allergy has been suggested to impact on children’s psychological wellbeing 
both directly and indirectly. Direct impact of food allergy may include increased 
anxiety due to the risk of accidental exposure,4 or the emotional impact for children 
who have experienced severe, potentially life-threatening allergic reactions, which 
would meet ICD-115 and DSM-56 definitions of a stressful event as required in the 
diagnosis of post-traumatic stress disorder. Indirectly, food allergy has been 
suggested to impact on child mental health through mechanisms such as indications 
of increased incidence of bullying in children with food allergy,7 which in turn has 
well-established links with anxiety and depression.8,9 
All the factors outlined above demonstrate how food allergy presents additional 
risks and threats for children to manage, which is a common feature across 
psychological models of anxiety.10 Whilst there is a lack of literature exploring health 
related beliefs in food allergy, the nature of the threat in food allergy involves a 
degree of uncertainty (i.e. due to the inability to completely control exposure to 
allergens), which is one factor suggested to increase anxiety in the wider literature.10–
16 
12 Furthermore, if avoidance of allergens leads to withdrawal from certain activities 
(e.g. social activities involving food), this would be suggested to impact on mood13 
as well as anxiety.10 Therefore, on the basis of psychological models and theory, one 
may reasonably predict that children with food allergy could be at elevated risk of 
experiencing mental health difficulties. Better understanding the presence and nature 
of mental health problems in children with food allergy is important for assessing the 
psychological needs and for adapting psychological interventions in this population. 
A review of the psychosocial impact of food allergy was previously conducted in 
2010.14 However, at the time of this review the majority of research had focused on 
quality of life rather than specific mental health problems. Only two studies were 
found using a validated measure of anxiety in a child food allergy population,15,16 no 
papers were found assessing depression in children with food allergy, and trauma 
was not included within the search terms of the review. Since this time, there has 
been a significant increase in research in the field; as such, there is a clear need for 
an updated synthesis. Furthermore, it is now possible to consider psychosocial 
impact in more detail, through the differentiation of broader quality of life and more 
specific mental health problems. The present review focuses on anxiety, depression, 
and post-traumatic stress due to the paucity of mental health research at the time of 
the previous systematic review. 
Therefore, the present review addresses two questions: 
1. What is the prevalence of anxiety, depression, and post-traumatic stress in 
children with food allergy? 
2. Do the levels of anxiety, depression, and post-traumatic stress symptoms 
in children with food allergy differ from normative samples? 
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Method 
This review was registered on PROSPERO (ID: CRD42018096212), an international 
prospective register of systematic reviews. 
 
Search Strategy 
The search included three databases: Medline, CINAHL and PsycINFO. The search 
included research from the start date of each database up to the 13th June 2018. The 
full search strategy is available is Supplementary Material 1; search terms included 
variants of anxiety, depression, or post-traumatic stress, and variants of allergy or 
anaphylaxis, as well as relevant index terms. 
 
Inclusion and Exclusion Criteria 
The inclusion criteria for the present review are summarised in Table 1. For all 
studies, food allergy could be self-reported, confirmed by a paediatrician/other 
relevant healthcare professional, or indicated by medical tests.  Mental health could 
be assessed through self-report measures or diagnostic interview. The approaches 
used to identify the food allergy and assess mental health were considered in the 
subsequent quality assessment and synthesis of the data. Where studies used a 
methodology that could meet inclusion criteria, but the required data were not 
reported in such a way that could be reliably extracted from the original paper, 
authors were contacted to attempt to obtain the relevant information. Where no 
response was provided by 2nd February 2019 these studies were excluded from the 
review.†  
†Any information received from authors after this date will be incorporated prior to 
submission to a journal; as of the 2nd February information from two studies was 
outstanding. 	
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Table 1. Review Inclusion and Exclusion Criteria 
 
Study Selection and Data Extraction 
The titles and abstracts were screened by the first author (KR) for potential 
eligibility. All full text articles were then screened by KR and a second reviewer 
(HE), blind to the other’s ratings. Any disagreements were discussed in relation to 
the outlined inclusion criteria, and where needed resolved by a third reviewer (JY). 
Data extraction was completed by KR using a pre-defined data extraction form. 
Where both parent and child rated mental health, but no aggregated measure was 
available, children’s self-report was extracted and included in the synthesis. 
 
Quality Assessment 
Due to the lack of a single recommended approach to the assessment of quality in 
systematic reviews of non-randomised control trials,17,18 a quality assessment tool 
Inclusion Exclusion 
• Anxiety, depression, and/or trauma 
symptoms assessed in children 
(age 0-17 years) with food allergy 
For prevalence:  
• Proportion of children with a 
diagnosis or clinically significant 
symptoms of above mental health 
conditions reported 
For difference: 
• Mean and N or proportion 
diagnosed for above mental health 
conditions reported for food 
allergy and comparison group 
• Comparison group aged 0-17 
years, general or healthy 
population, and same mental 
health assessment as food allergy 
group 
• Non-English Language 
• Non-peer reviewed studies 
• Adult population (over 17 years) 
• Non-allergic food reactions (e.g. 
coeliac disease) 
• Non-food allergy 
• Studies reporting no new data or 
only qualitative data 
  For prevalence:  
• Measures of general mental 
health symptomology with no 
defined clinical cut-off 
  For difference: 
• Comparison to previously 
published norms 
• Comparison groups that may 
include children with food 
allergy 
19 
was developed for the purpose of the review (Supplementary Material 2). The tool 
was primarily based on the Joanna Briggs Institute Checklist for Prevalence Studies19 
and the Newcastle-Ottawa Quality Assessment Scale,20 incorporating relevant items 
from these measures adapted to the food allergy population being reviewed. The 
assessment was used to guide an informed categorical judgment of each study as 
high, medium, or low risk of bias.  An additional criterion was included on the basis 
of a critique of meta-analyses in the paediatric psychology literature,21 whereby any 
study with a sample size less than 35 per group were considered high risk of bias. All 
studies were quality assessed by KR, with approximately one third also reviewed by 
another individual (HC), and any disagreements resolved by a third reviewer (JY). 
 
Synthesis Approach 
For the first review question, meta-analysis of prevalence was conducted using 
OpenMeta. For the second review question, all between group differences were 
converted to Cohen’s d effect sizes. These effect sizes were then pooled using 
MAVIS v1.1.3. Both OpenMeta and MAVIS make use of the metafor package for R. 
In all cases, random-effects model meta-analyses were used, and 95% confidence 
intervals are reported. All analyses were re-run removing studies considered to be at 
high risk of bias. Meta-analyses were run where there was a minimum of two studies 
after the removal of those considered high risk of bias. Where this criterion was not 
met, results were tabulated and synthesized narratively. Due to the small numbers in 
each synthesis, it was not considered appropriate to explore moderators statistically, 
where high degrees of heterogeneity were observed, possible reasons for this are 
discussed.  
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Results 
Figure 1 shows a PRISMA diagram summarising study selection. After removing 
duplicates 2597 studies were found in the search. The reference list of the previous 
systematic review14 was also checked but did not lead to the inclusion of any 
additional studies. Two reviewers screened the full-text of 98 articles, with seven 
articles (7.1%) also discussed with a third reviewer. 14 studies were included in the 
synthesis, 11 for the prevalence synthesis and seven for the difference synthesis. 
Broad exclusion reasons are listed in Figure 1. A subset of studies assessed food 
related anxiety,22–29 most often using the Food Allergy Quality of Life – Parent Form 
subscale.25 While food related anxiety is important to consider, these studies were not 
included in the present review as there is currently no agreed threshold for clinically 
significant food related anxiety to establish prevalence, and it is not possible to 
meaningfully compare this in non-food allergy populations. Two studies were 
excluded due to comparing outcomes to previously established norms.15,30 
Additionally, as only one study reported lifetime mental health31 in food allergy, and 
this study used a self-disclosure of diagnosis rather than a validated measure, a 
decision was made to only include studies that assessed current anxiety, depression, 
or post-traumatic stress within the prevalence analysis. Two additional studies were 
included on the basis of additional information received from authors.32,33 
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Full-text articles excluded  
(n = 84): 
Unsuitable or irrelavant 
outcome measures, or unable 
to extract necessary 
infomation  
(n = 29) 
Adult population  
(n = 20) 
Not patient population (e.g. 
non-allergy)  
(n = 29) 
Inappropriate study design 
(n = 2) 
Comparison to previously 
published norms  
(n = 2) 
Duplicate data  
(n = 2) 
 
Records identified through database searching: 
n = 3019  
(Medline n = 1974; CINAHL n = 489;  
PsycINFO n = 556) 
Records after duplicates removed: 
n = 2597 
Full-text articles assessed for 
eligibility: 
n = 98 
Studies included in qualitative synthesis: 
n = 14  
(Review question 1 n = 11; Review 
question 2 n = 7) 
Studies included in quantitative synthesis 
(meta-analysis): 
n = 13  
(Review question 1 n = 10; Review question 
2 n =7) 
Excluded at title/abstract 
screen: 
n = 2499 
Figure 1. PRISMA Diagram showing studies included and excluded from review with 
reasons. 
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Quality assessment ratings of all studies included in the synthesis are 
displayed in Table 2. Five studies were second rated, with one disagreement 
(Cohen’s κ=.71) between low and medium risk of bias resolved by a third reviewer. 
Four studies were considered to be high risk of bias, in all cases this was due to small 
sample sizes.  
 
Table	2. Overall Quality Assessment Ratings of Included Studies 
 
 
Review Question 1: Prevalence 
Details of the studies included in the prevalence synthesis are displayed in Table 3. 
The 11 studies included in the prevalence synthesis included a total of 2228 children 
with food allergy, and reported 26 estimates of prevalence covering eight specific 
mental health conditions and measures of non-disorder specific anxiety. Twenty-one 
of these prevalence estimates were included in quantitative synthesis.
Risk of Bias Study (First author (year)) 
Low Brew (2018) 
 Fedele (2016) 
 Ferro (2016) 
 Lau (2014) 
 LeBovidge (2009) 
 King (2009) 
Medium Annunziato (2015) 
 Fox (2017) 
Rubes (2014) 
 Shanahan (2014) 
High Butler (2018) 
 Goodwin (2017) 
 LeBovidge (2014) 
 Weiss (2016) 
 Table 3. Summary of Studies Included in Prevalence Synthesis 
First 
Author, 
year 
Study 
Setting
a 
Design
b 
Food 
Allergy 
Diagnosisc 
Age 
Range 
(years) 
% 
Male 
Food 
Allergy 
N 
Mental 
Health 
Measure(s) 
(parent/ 
child 
report)d 
% Clinically Significant Symptoms or Diagnostic Criteria Metd 
       Any 
Anx 
Sep Phobia Panic GAD Soc Dep PTSS PTSD 
Annunziato, 
201534 
Clinic C M 8-17  61 249 MASC-10 
(C) t score 
61+ 
14 - - - - - - - - 
Brew, 201833 Comm
unity 
L S 9  47 1330 SCARED 
(anx; P), 
SMFQ (dep; 
P)  
16 - - - - - 2 - - 
Butler, 
201835 
Clinic 
(ND) 
P M 6-16 - 8 MINI-KID 
(P) 
- 0 38 - 25 - 13 - - 
Fedele, 
201632 
Clinic C M (IgE) 6-12 65 60 MASC (C) t 
score 70+ 
2 5 - - - 3 - - - 
Ferro, 201636 Comm
unity 
L S 14  55 268 YSR (C) 22 - - - - - 19 - - 
Fox, 201737 School C S 13-17  - 87 MASC 
Social 
anxiety 
subscale (C) 
- - - - - 19 - - - 
Lau, 201438 Clinic C M (IgE) 8-16 68 40 SCARED 
(P) 
20 23 - 13 23 10 - - - 
LeBovidge, 
201439 
Clinic 
(OIT) 
P T (Peanut) 7-15 60 13 SCARED – 
generalized 
and panic 
subscales (P) 
- - - 0 8 - - - - 
 First 
Author, 
year 
Study 
Setting
a 
Design
b 
Food 
Allergy 
Diagnosisc 
Age 
Range 
(years) 
% 
Male 
Food 
Allergy 
N 
Mental 
Health 
Measure(s) 
(parent/ 
child 
report)d 
% Clinically Significant Symptoms or Diagnostic Criteria Metd 
Any 
Anx 
Sep Phobia Panic GAD Soc Dep PTSS PTSD 
LeBovidge, 
200940 
Clinic 
and 
Non-
Profit 
Organis
ation  
C M 8-17 60 70 MASC 
(anxiety t 
score 70+; 
C), BASC-2 
(depression; 
C) 
5 14 - - - - 0 - - 
Rubes, 
201441 
Clinic I S 8-17  52 78 SCARED – 
generalized 
anxiety 
subscale (C) 
- - - - 15 - - - - 
Weiss, 
201642 
Clinic 
(PFC) 
P M (Ana) 7-13  56 25 Child PTSD 
Symptom 
Scale (C) 
- - - - - - - 36 8 
aPFC = post food challenge; OIT = after consenting to Oral Immunotherapy Trial; ND=newly diagnosed (within 6 months), if not specified time point not controlled for in 
study. 
bC=cross-sectional, L=longitudinal, I=intervention (baseline data used), P=pilot study (baseline data used where intervention pilot).  
cM=medical records or confirmed by healthcare professional, S=self or parent report, T=recognised allergy testing completed in study. IgE = reaction was required to be 
confirmed IgE-mediated; Ana = anaphylaxis plan or history of anaphylaxis required. Unless specified, any food allergens were included. 
dMASC-10 = Multidimensional Anxiety Scale for Children-10; SCARED = Screen for Child Anxiety Related Disorders; SMFQ = Short Mood and Feelings Questionnaire; 
MINI-KID = Mini International Neuropsychiatric Interview for Children and Adolescents; MASC = Multidimensional Anxiety Scale for Children; YSR = Youth Self-Report; 
BASC-2 = Behavior Assessment System for Children Second Edition 
dSep = separation anxiety; Soc = social anxiety; Dep = depression
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Anxiety (non-disorder specific) 
Six studies reported on the number of children experiencing clinically significant 
anxiety on non-disorder specific measures. Meta-analysis of these studies yielded a 
pooled estimated prevalence of clinically significant anxiety of 12.6% (CIs 6.0% - 
19.3%; n=2017). However, estimates of heterogeneity indicated high levels of 
variance between the studies (I2=94.0%). No studies were considered to have a high 
risk of bias.  
 
Social Anxiety 
Three studies reported on the number of children experiencing clinically significant 
social anxiety; none of these studies were considered to be high risk of bias. Pooling 
these studies generated an estimated prevalence of 10.1% (CIs 0.1% - 19.6%; 
n=187). Again, estimates of heterogeneity indicate a high level of variance between 
studies (I2=80.7%), and as the pooled sample size was small particular caution is 
therefore needed in interpreting this result. 
 
Separation Anxiety 
Four studies reported the prevalence of separation anxiety in children with food 
allergy, one of which was considered high risk of bias.35 Estimated prevalence of 
separation anxiety is 11.2% (CIs 3.4%-19.0%; n=178). Estimates of heterogeneity 
indicate a moderate-high level of variance (I2=62.5%). Removing the study 
considered to be high risk of bias resulted in a very small increase in the estimated 
prevalence and increased the heterogeneity (12.6%, CIs 3.0-22.2%; I2=74.2%).  
The differences in estimated prevalence may reflect differences in 
methodology. Whilst all four studies reported on children with medically diagnosed 
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food allergy, three different anxiety measures were used, including different 
timeframes (one-month, three-month, recently) and informants (child/parent). 
Although interestingly, of the two most closely comparable studies,32,40 higher 
prevalence of separation anxiety was observed in the study with a slightly older 
sample40 contrary to what would be expected from the wider anxiety literature.43 
 
Generalized Anxiety Disorder/Worry  
Four studies investigated generalized anxiety disorder or clinically significant worry 
in children with food allergy, two of which were considered to be high risk of 
bias.35,39 Estimated prevalence was 16.0% (CIs 9.9%-22.0%; n=139), with 
heterogeneity estimates indicating little variance (I2=0.0%). Removing the studies 
considered to be high risk of bias resulted in a small increase in estimated prevalence 
(17.4%, CIs 10.5%-24.2%; I2=0.0%). 
 
Panic and Phobia 
Two studies reported on panic, but as one of these studies was considered high risk 
of bias39 the results were not combined statistically. One additional study assessed 
specific phobia. Given the heterogeneity, small number of studies, and generally 
small sample sizes, it is not possible to draw conclusions on prevalence for these 
conditions. 
 
Depression 
Current rates of depression were reported by four studies, one of these studies was 
considered to be a high risk of bias.35 Including all studies, prevalence was estimated 
as 6.9% (CIs 1.3%-12.5%; n=1676). A high degree of variance between studies was 
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found (I2=94.2%). Removing the study considered to be high risk of bias, made little 
difference to the results (6.6%, CIs 0.8%-12.4%; I2=96.1%).  
 
PTSS/PTSD 
Only one study was found assessing PTSS or PTSD in children with food allergy, 
finding 36% of participants to report clinically significant PTSS and 8% to meet 
PTSD criteria. However, this was a pilot study, and therefore had a small N. 
Moreover, post-traumatic stress was also assessed immediately following a food 
challenge, which may have affected the results.  
 
Review Question 2: Difference 
The studies included in the synthesis for the second review question are outlined in 
Table 4. The studies provided 23 estimated effect sizes for difference, covering six 
specific mental health conditions and studies using measures of any anxiety. Twenty-
two of these comparisons were included in statistical synthesis. For all meta-
analyses, funnel plots were inspected for indications of publication bias. Whilst the 
small numbers of studies in each synthesis reduce how interpretable these plots are, 
no clear indicators of publication bias were observed for any of the following 
analyses.
 Table 4. Summary of Studies Included in Difference Synthesis 
First 
Author, 
year 
Study 
Setting 
(Design)a 
Food 
Allergy 
(FA) 
Diagnosisb 
Comparison 
Group  
Age 
Range, 
years 
Food 
Allergy 
N (% 
male) 
Comp 
Group 
N (% 
male) 
MH 
Measure 
(parent/ 
child 
report)c 
Cohen’s d [95% CIs]d 
  Any 
Anx 
Sep GAD Panic Soc OCD Dep 
Brew, 
201833 
Commun
ity (L) 
S No current or 
historic 
atopic 
disease 
9 1330 
(47%) 
8392 
(full 
cohort 
50.4%) 
SCARED 
(anx; P), 
SMFQ 
(dep; P) 
0.22 
[0.16, 
0.27] 
- - - - - 0.45 
[0.39, 
0.51] 
Ferro, 
201636 
Commun
ity (L) 
S Same birth 
cohort with 
no FA or 
other health 
condition 
14 268 
(55%) 
1035 
(53%) 
YSR (C) 0.15 
[0.01, 
0.28] 
- - - - - 0.19 
[0.06, 
0.33] 
Fox, 
201737 
School 
(C) 
S No self-
reported FA 
13-17 87 
(-) 
762 
(-) 
MASC 
Social 
anxiety 
subscale 
(C) 
- - - - 0  
[-0.22, 
0.22] 
- - 
Goodwin, 
201744 
Clinic 
(C) 
M Paediatric 
outpatients 
with no 
history of FA 
4-12 16 
(anx); 
20 
(dep). 
(48%) 
27 
(anx); 
31 
(dep). 
(53%) 
MASC 
(anx: C); 
CDI (dep; 
C) 
0.94 
[0.27, 
1.57] 
0.46  
[-0.17, 
1.08] 
- - 0.83 
[0.17, 
1.46] 
- 0.16  
[-0.41, 
0.72] 
King, 
200916 
Clinic 
(C) 
M 
(Peanut) 
Older 
siblings 
without FA 
FA: 8-
12; 
Comp: 
8-15 
46 
(65%) 
46 
(37%) 
SCAS (C) 0.19  
[-0.22, 
0.60] 
0.52 
[0.10, 
0.93] 
0.07  
[-0.34, 
0.48] 
0.20  
[-0.21, 
0.61] 
-0.11 
[-0.52, 
0.30] 
0.11  
[-0.3, 
0.53] 
- 
	 	
 First 
Author, 
year 
Study 
Setting 
(Design)a 
Food 
Allergy 
(FA) 
Diagnosisb 
Comparison 
Group  
Age 
Range, 
years 
Food 
Allergy 
N (% 
male) 
Comp 
Group 
N (% 
male) 
MH 
Measure 
(parent/ 
child 
report)c 
Cohen’s d [95% CIs]d 
Any 
Anx 
Sep GAD Panic Soc OCD Dep 
Lau, 
201438 
Clinic 
(C) 
M 
(IgE) 
Hospital 
outpatients 
with no 
chronic 
atopic or 
non-atopic 
disease 
8-16 40 
(68%) 
38 
(68%) 
SCARED 
(P) 
0.16  
[-0.29, 
0.60] 
0.05  
[-0.40, 
0.49] 
0.50 
[0.04, 
0.94] 
0.52 
[0.06, 
0.97] 
-0.17 
[-0.61, 
0.28] 
- - 
Shanahan, 
201445 
Commun
ity (L) 
S Same 
population 
with no 
parent 
reported FA 
10-16 136 
(46.3%) 
5029 
(-) 
CAPA 
(P&C) 
- 0.41 
[0.24, 
0.58] 
0.38 
[0.21, 
0.55] 
- - - 0.24 
[0.07, 
0.41] 
aC=cross-sectional, L=longitudinal 
bM=medical records or confirmed by healthcare professional, S=self or parent report. IgE = reaction was required to be confirmed IgE-mediated. Unless specified, any food 
allergens were included. 
cSCARED = Screen for Child Anxiety Related Disorders; YSR = Youth Self-Report; MASC = Multidimensional Anxiety Scale for Children; SCAS = Spence Children’s 
Anxiety Scale; CDI=Children’s Depression Inventory; CAPA= Child and Adolescent Psychiatric Assessment 
dSep = separation anxiety; Soc = social anxiety; Dep = depression
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Anxiety (Non-disorder specific) 
The combined effect size for the five studies assessing non-disorder-specific anxiety 
was 0.21[0.16, 0.26], p<.001 (food allergy n=1700; comparison n=9538). This 
indicates a small but significant increase in anxiety reported for children with food 
allergy. There was no significant heterogeneity between studies, Q(4) = 5.57, 
p=0.234, I2=0.05%. Removing the one study considered to be a high risk of bias,44 
did not notably change these results (0.20[0.15, 0.26], p<.001).  
 
Social Anxiety 
The combined effect size for four studies comparing social anxiety in children with 
food allergy to those without did not find a significant difference, 0.06[-0.26, 0.38], 
p=.711 (food allergy n=189; comparison n=873). There was a moderate degree of 
variability between studies, Q(3) = 6.99, p=.072. I2=59.98%. The variability 
decreased when the high risk of bias study44 was removed, Q(2) = 0.55, p=0.759, 
I2=0.00%. However, there remained no significant difference between the groups,     
-0.05[-0.23, 0.13], p=0.598.  
 
Separation Anxiety 
The combined effect size for separation anxiety (k=4) was 0.39[0.24, 0.53], p<.001 
(food allergy n=238; comparison n=5140). This indicates significantly higher 
separation anxiety in children with food allergy with a small effect size. There was 
not significant variability between the studies, Q(3) = 2.74, p=0.434. I2=0.00%. 
These results were maintained when the one high risk of bias study44 was removed 
(0.38[0.23, 0.53], p<.001). The smallest effect size was observed for the only study 
to use exclusively parent reported anxiety.38 
31 
Generalized Anxiety 
Three studies compared generalized anxiety disorder or worry in children with and 
without food allergy, finding significantly higher anxiety in children with food 
allergy with a small effect size, 0.35[0.20, 0.50], p<.001 (food allergy n=222; 
comparison n=5113). No studies were considered to be high risk of bias, and there 
was no significant heterogeneity between studies, Q(2) = 2.32, p=0.314, I2=0.00%. 
The smallest effect size was reported by the only study using exclusively child 
report,16 however this study also had an older comparison group, which may affect 
results.43  
 
Panic 
Two studies compared panic in children with and without food allergy, 
finding significantly higher panic with a small effect size, 0.34[0.03, 0.65], p=.030 
(food allergy n = 86; comparison n = 84). Neither study was considered high risk of 
bias, and the heterogeneity was not significant, Q(1) =1.04, p=.307, I2=4.19%. 
However, the confidence intervals were wider than for both separation and 
generalized anxiety, with the lower confidence interval indicating no difference in 
panic disorder. 
 
Obsessive Compulsive Disorder 
One study assessed obsessive compulsive disorder finding an effect size of 
0.11, which indicates no clear difference between children with and without food 
allergy.  
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Depression 
The combined effect size for the four studies assessing depression was 0.30[0.14, 
0.45], indicating significantly higher depression in children with food allergy with a 
small effect size (p<.001). There was significant variation between studies, Q(3) = 
15.73, p=.001, I2=76.00%. Removing the one study considered high risk of bias44 did 
not notably change the combined effect size, 0.31[0.14, 0.47], p<.001. The variation 
between the studies appears largely due to the larger effect size found by the only 
study to use exclusively parent report.33 However, as there were further differences 
between all three studies (e.g. in the depression measure used), there may be 
different factors responsible for this heterogeneity. 
 
Discussion 
The present review synthesised the research assessing anxiety, depression, and post-
traumatic stress in children with food allergy. The estimated prevalence rates for 
current overall anxiety and depression were 12.6% (95% CIs 6.0-19.3%) and 6.9%  
(95% CIs 1.3-12.5%) respectively. However, there was a high degree of 
heterogeneity in the methodology and prevalence estimates between studies, 
meaning caution is needed in interpreting these results. There was also relatively 
little consistency in the anxiety disorders reported in research, and notably only one 
pilot study assessed post-traumatic stress in children with food allergy.  
Prevalence estimates for any anxiety and depression were both higher than 
general child population estimates of 6.5% and 2.9% respectively.46 Although 
general population reviews have been able to use stricter inclusion criteria due to the 
wider literature available, which limits the comparability of these estimates.  
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Small but significant increases in anxiety (d=0.21) and depression (d=0.30) were 
found in children with food allergy compared to children without food allergy. This 
compares to average effect sizes of 0.18 (anxiety) and 0.19 (depression) previously 
found for children with and without any chronic health condition.1,2 Whilst, the effect 
size for depression calculated in the current review is larger than the previous 
estimates for any health condition, the heterogeneity in the depression synthesis 
limits the robustness of this finding.  
Despite the variability in methodologies and prevalence estimates, relatively little 
heterogeneity was observed in the synthesis of studies comparing anxiety in children 
with and without food allergy, adding confidence to these the results. However, 
differences were found between anxiety disorders, with small effects found for 
generalized anxiety (0.35) and separation anxiety (0.39), but no significant difference 
found for social anxiety (0.06), demonstrating the utility of assessing different forms 
of anxiety. This pattern of results appears in keeping with the nature of food allergy. 
In particular, as the management of food allergy includes avoidance of allergens, 
children with food allergy may find it harder to be away from home or parents 
(separation anxiety) and/or worry more (GAD). Whilst it has been suggested that a 
degree of anxiety may be adaptive for allergy management,22 if this anxiety is 
negatively impacting on wellbeing, it is important to consider ways to offer support 
for anxiety whilst maintaining the necessary caution surrounding allergen exposure. 
There has been substantial growth in the literature exploring mental health in 
children with food allergy in recent years (all studies meeting review inclusion 
criteria were published between 2009 and 2018); however, the overall body of 
evidence remains relatively small, limiting the present review. Firstly, it was not 
considered meaningful to statistically explore any moderators, which would have 
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been particularly beneficial given the wide range of methodologies used. 
Furthermore, additional variables that may act as moderators between food allergy 
and mental health outcomes, such as bullying or the time since allergic reaction, 
were rarely reported in research. This is particularly concerning given the majority of 
research uses a solely cross-sectional design, which is not able to establish causality.  
As is typical in paediatric psychology literature, the review was also limited by 
the sample size within studies. Nearly a third of studies (4/14) had a food allergy 
sample size of less than 35, and were considered to be high risk of bias. Within the 
prevalence syntheses, even pooled sample sizes were at times smaller than would be 
ideal for a single prevalence study. For feasibility reasons, the current review also 
excluded non-English language studies and grey literature. It is possible that this 
would have led to the inclusion of additional studies, which may have reduced issues 
associated with the small k and N.   
Finally, the current study focused on mental health measures thereby excluding 
food related anxiety, due to the lack of an established clinical cut-off for these 
measures. Future research exploring food allergy related anxiety may help to 
distinguish whether elevated anxiety is an adaptive response or of greater concern 
and therefore warranting intervention.  
Despite these limitations, the review utilized a systematic approach to synthesize 
the current literature. This also highlights areas that warrant further consideration. 
Firstly, there is a clear need for research investigating post-traumatic stress in 
children with food allergy.  Post-traumatic stress has been reported in children with 
other health conditions, e.g. asthma47 and diabetes.48 However, despite being a 
common health condition, which can sometimes cause a life-threating reaction, there 
has been only one attempt to assess post-traumatic stress in food allergy. It would be 
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beneficial for this research to include longitudinal assessments, e.g. following 
diagnosis and/or allergic reactions, to allow greater consideration of causality and 
adaptation over time. Secondly, the review highlights the need for further larger scale 
studies that include sub-types of anxiety, depression and possible moderators.  
Overall, this review provides a systematic summary of the current evidence base 
for anxiety, depression, and post-traumatic stress in children with food allergy. 
Whilst it is positive to note the substantial growth in literature in this field, there are 
significant limitations in the evidence base due to generally small sample sizes, 
differences in methodology, and limited consistent reporting of possible moderators.  
The synthesis indicates children with food allergy may experience a small but 
significant increase in anxiety and depression compared to their peers without food 
allergy. The most consistent results were found for studies assessing differences in 
anxiety, but the review highlighted the importance of considering different forms of 
anxiety rather than using only non-disorder specific measures. The synthesis 
indicates children with food allergy may experience greater separation anxiety and 
generalized anxiety compared to their peers, but no greater social anxiety. However, 
until research is available addressing the current limitations in the field, any 
conclusions drawn on the relative prevalence of mental health in children with food 
allergy remain tentative. 
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Supplementary Material 1: Details of Search Strategy 
 
 
The following search terms were used for all three databases (Medline, CINAHL, 
PsychINFO): 
 
anxi* OR panic OR phobi* OR worry OR depress* OR “posttraumatic stress” OR 
“post-traumatic stress” OR “post traumatic stress” OR mental health index terms (see 
below) 
AND 
allergy OR allergies OR allergic OR allergen OR allergens OR anaphylaxis OR 
anaphylactic OR “food hypersensitivity” OR “adverse food reaction” OR food 
allergy index terms (see below) 
 
Relevant exploded index terms were included for each database. For Medline, this 
included the MeSH terms: “Anxiety” “Anxiety Disorders” “Depression” “Depressive 
Disorder” “Psychological Trauma” “Trauma and Stressor Related Disorders” and 
“Food Hypersensitivity”. For CINAHL, the CINAHL headings: “depression” 
“anxiety” “anxiety disorders” “trauma” “stress disorders, post-traumatic” and “food 
hypersensitivity”. For PsycINFO, the PsycINFO thesaurus terms: “anxiety” “anxiety 
disorders” “depression (emotion)” “major depression” “trauma” and “food allergy”. 
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Supplementary Information 2: Quality Assessment Rating Tool 
 
 
Quality Assessment Tool 
 
For all studies: 
1. How was the food allergy identified? 
a. Medical records/Physician confirmed 
b. Confirmed by recognized tests/approach by qualified professional 
c. Self-diagnosed or other 
2. Was mental health assessed using a validated tool? 
a. Yes – validated diagnostic interview 
b. Yes – validated self-report questionnaire 
c. No 
3. Was mental health measured reliably? 
a. If relevant, was researcher trained in the use of the tool? 
b. Was the measure completed as intended (e.g. self vs parent vs 
professional report)? 
c. Was the measure completed in the same way for all participants? 
4. Was the response rate adequate (50%+)? If not were steps taken to account 
for this? 
Yes 
No 
5. Were participants and the setting described in detail? 
Yes 
No 
6. Was the sample size at least N=35 (per group where relevant)? 
Yes 
No 
 
For comparison: 
1. Was the comparison group recruited from the same community as the allergy 
group? 
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a. Yes – another clinical group recruited from same setting and 
approximate time period, with the same inclusion criteria used (other 
than health status) 
b. Yes – healthy controls recruited from same region and approximate 
time period, with the same inclusion criteria used (other than health 
status) 
c. No 
2. How was the comparison group defined: 
a. No current or historic food allergy (medical records) 
b. No current or historic food allergy (self-report) 
c. No current food allergy  (medical records or recognized tests by 
qualified professionals) 
d. No current food allergy (self-report) 
AND: 
e. No current long term health condition (medical records) 
f. No current long term health condition (self-report) 
g. Included on basis of having another condition (medical records) 
h. Included on basis of having another condition (self-report) 
i. General population sample other than exclusion of food allergy 
3. Was the same method of data collection used for the allergy and comparison 
groups? 
Yes 
No 
4. Was the comparison group comparable to the allergy group on other (e.g. 
demographic) factors? If not, was this adequately controlled for? 
Yes 
No 
5. Was the response rate similar for both groups? 
Yes 
No 
 
 
Overall Judgment: ___________________________ 
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Guidance 
Low Risk of Bias 
Study generally well designed, with possible limitations (e.g. differences in 
demographics between groups) adequately controlled for in the analysis. All relevant 
measures/diagnostic interviews were valid and reliable. To be considered low risk of 
bias studies must have an adequate sample size. 
 
Medium Risk of Bias 
There may be some concerns over the quality of the study, which may include, but 
are not limited to:  
• Representativeness of the sample (e.g. bias in sampling/recruitment method) 
• Food allergy diagnosis based exclusively on self-report 
• Differences between the allergy and control groups (that are not adequately 
controlled for in the analysis) 
However, overall the study is considered to be of adequate quality, given the 
practicalities of research, with no cause for significant concern (e.g. very small 
sample sizes, non-validated outcome measures). 
 
High Risk of Bias 
Significant concerns about the quality of the study, including very small sample sizes 
(N less than 35 per group), non-validated outcome measures, or an accumulation of 
medium risk factors. 
 
Unable to rate 
 Insufficient information was available to judge the quality of the study. 
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Chapter 2: Bridging Chapter 
 
The previous chapter summarised the literature assessing mental health in children 
with food allergy. However, when considering the psychological impact of paediatric 
health conditions it is also important to consider those surrounding the child, 
particularly those with main caring responsibility (i.e. parents/guardians, from here 
on in parents is used to refer to any adult with this responsibility). In the wider 
paediatric literature, increased anxiety has been found in mothers of children with 
any chronic illness (van Oers et al., 2014), as well as parents of children with various 
specific health conditions including diabetes (e.g. Streisand et al., 2008) and epilepsy 
(Jones & Reilly, 2016). Furthermore, parents have been reported to experience post-
traumatic stress symptoms (PTSS), in relation to paediatric medical events (e.g. 
burns; Hawkins, Centifanti, Holman, & Taylor, 2019) and health conditions 
(including asthma, Kean, Kelsay, Wamboldt, & Wamboldt, 2006; and cancer, 
Sharkey et al., 2018). 
 Arguably, it is of particular importance to consider the psychological impact 
for parents in conditions such as food allergy that are most commonly diagnosed in 
infancy or early childhood (Sicherer & Sampson, 2010). In infants and very young 
children, parents initially hold responsibility for managing a condition that the child 
is unlikely to have awareness of. In food allergy this can mean that children can grow 
up with allergy management being a normal part of their routine, and may not have 
any recollection of allergic reactions. Where this is the case, parent’s experience and 
perception of food allergy could be expected to be more notably different from their 
child’s (e.g. Akeson, Worth, & Sheikh, 2007).  Furthermore, due to difficulties with 
assessing anxiety or other mental health problems in young children (Carpenter, 
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Sprechmann, Calderbank, Sapiro, & Egger, 2016), assessing parent mental health 
allows the inclusion of a wider proportion of the food allergy population in research. 
As well as the clear importance for parents’ own wellbeing, consideration of 
parent mental health is also important due to the possible knock on effects for child 
wellbeing. A recent meta-analysis (Lawrence, Murayama, & Creswell, 2019) found 
evidence for elevated anxiety and depression in children of parents with anxiety 
disorders. Interestingly, whilst there was no evidence of specificity (i.e. children 
being more likely to experience the same anxiety disorder as their parent), children 
of parents with an anxiety disorder were found to be at increased risk of experiencing 
generalized anxiety and separation anxiety. However, children of parents with an 
anxiety disorder were not found to be significantly more likely to experience social 
anxiety. This is the same pattern of results observed in the meta-analysis chapter 
within this portfolio. A better understanding of the mental health of parents of 
children with food allergy may therefore also contribute to a better understanding of 
the psychological impact for children.  
The following chapter reports on an original piece of empirical research 
assessing anxiety and post-traumatic stress in parents of children with food allergy. It 
is first useful to give additional consideration to the models available to guide this 
research.  
Despite the growing evidence base exploring the psychological impact of 
physical health problems for children and their parents, few attempts have been made 
to develop psychological models specific to this population, a notable exception 
being the integrative model of paediatric traumatic stress.  Kazak et al. (2006) 
developed the integrative model of paediatric medical traumatic stress, which was 
subsequently updated by Price, Kassam-adams, Alderfer, Christofferson, & Kazak 
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(2016) to reflect the growing evidence base. The model considers patterns of 
psychological response to a potentially traumatic medical event over three stages: 
peri-trauma (the initial potentially traumatic event and immediate responses), acute 
medical care (demands associated with period of active treatment), and ongoing care 
or discharge from care (time following active treatment). The model highlights the 
importance of the interactions between medical events and individual and family 
responses, in doing so the model focuses on commonalities across health conditions 
(e.g. in terms of psychological risk factors for the development of PTSS) whilst 
acknowledging differences between conditions, for example in terms of the nature of 
the potentially traumatic event, and length and invasiveness of treatment. The model 
places particular emphasis on an individual’s perception of the potentially traumatic 
event as threatening (e.g. perceived risk of death), as this has consistently been found 
to be a good predictor of significant PTSS across the literature (Price et al., 2016). 
However, due to the lack of available research, the model offers limited specificity 
regarding broader individual or social factors that may increase risk of PTSS.  
As a model of traumatic stress, Price et al.’s (2016) model is also not designed to 
assess the broader psychological impact of paediatric health. In particular, while it is 
apparent how the model could be applied following a severe allergic reaction, it is 
less clear if or how the model would be applied in situations where there is neither a 
single acute medical emergency (e.g. as in burns) nor ongoing active treatment (e.g. 
as in diabetes), as somewhat unusually the main management of food allergy is 
avoidance rather than the addition of medication or medical procedures. As the aim 
of the research presented in the following chapter was to assess anxiety more 
generally as well as PTSS, and was interested in including the full spectrum of food 
allergy severity, the research drew more heavily on a general model of anxiety, given 
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the possible limitations of applying the integrated model of paediatric medical 
traumatic stress in this instance. 
Clark and Beck's (2010) transdiagnostic CBT model of anxiety (replicated below 
in Figure 2 and discussed further in the following chapter), shows commonality with 
the integrated model of paediatric medical traumatic stress in considering the nature 
and perception of a potential threat and an individual’s responses to this. However, 
Clark and Beck’s model is much broader in nature, being developed on the basis of 
the much wider anxiety literature; as such, it provides more suggestion of individual 
factors that impact on anxiety responses. Furthermore, through focusing on the 
similarities across, rather than differences between, anxiety disorders it offers a 
useful framework for approaching areas with limited pre-existing research, as is the 
case in food allergy. Cross-referencing the available food allergy literature, 
experience of clinicians working in food allergy, and suggestions from the Clark and 
Beck model, was therefore considered the most appropriate way to determine 
variables that could be of particular interest to explore in the following study. 
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Figure 2. Cognitive Model of Anxiety, replicated from Clark, D.A., & Beck, A.T. (2010). Cognitive Therapy of Anxiety Disorders: 
Science and Practice. New York: Guildford Press. 
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Chapter 3: Empirical Research Project 
 
The following paper has been prepared in accordance to the Journal of Pediatric 
Psychology, author guidelines can be found in Appendix C. Tables have been 
included in position for the purpose of the portfolio. Due to the differing 
requirements for margins and page formatting for the thesis portfolio, the paper 
appears to exceed the journal page limit.  Additional documents included for the 
purpose of the thesis portfolio only are included in the appendices and indicated in 
text, the Food Allergy Self-Efficacy Scale for Parents (Knibb, Barnes, & Stalker, 
2015) is not included in the appendices for copyright reasons. 
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Abstract 
Objective   The purpose of this study was to explore anxiety, worry, and post-
traumatic stress symptoms (PTSS) in parents of children with food allergies, and to 
evaluate whether these three psychological outcomes could be predicted by allergy 
severity, intolerance of uncertainty, and food allergy self-efficacy.  Methods  
Participants were 105 parents who reported their children to have medically 
diagnosed food allergies. Participants were recruited to a study on parent wellbeing 
through an allergy clinic and social media advertisements. Participants completed 
online questionnaires assessing anxiety, worry, PTSS, intolerance of uncertainty, 
food allergy self-efficacy, and demographic and allergy information.  Results  81.0% 
parents reported clinically significant worry, 42.3% met the clinical cut-off for PTSS, 
and 39.1% reported moderate-extremely severe anxiety. Regression models 
including allergy severity, intolerance of uncertainty, and food allergy self-efficacy 
were significant for all three psychological outcome measures. However, intolerance 
of uncertainty was the only variable to consistently be significantly predictive in 
these models. Conclusions  This study highlights the need for greater awareness of 
mental health in parents of children with food allergy. The study also indicates that 
factors impacting on parents’ perception of threat may be most strongly predictive of 
psychological outcomes, warranting further research. Finally, the study indicates that 
intolerance of uncertainty may be a promising target for psychological interventions 
within this population. 
Key words: food allergy, paediatric, parental anxiety, worry, post-traumatic stress  
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Introduction 
Food allergies have become increasingly common in recent years, with 
prevalence in children of around 6-8% (Luyt, Ball, Kirk, & Stiefel, 2016). Food 
allergies can vary widely in severity, but all will involve an adverse immune reaction 
to a particular allergen, with symptoms including changes to the skin, 
gastrointestinal, and respiratory systems, with the most severe cases leading to 
anaphylaxis (National Institute for Health and Clinical Excellence; NICE, 2011a).  
The medical management of food allergies is primarily avoidance, this can be 
challenging as even with careful management exposure to allergens can occur 
(Boyce et al., 2010), for example through accidental exposure or cross-contamination 
during food preparation.  
Research has started to explore the impact that living with a food allergy 
could have for an individual’s mood and quality of life (e.g. Cummings, Knibb, 
King, & Lucas, 2010). As food allergies are most prevalent in childhood (Boyce et 
al., 2010), this research has included the psychosocial impact that caring for a child 
with food allergy may have for their parents, as initially caregivers often have the 
primary responsibility for allergy management.  Previous research has typically 
found increased anxiety and stress in parents, particularly mothers, of children with 
food allergy (e.g. Cummings, Knibb, King, & Lucas, 2010; Lau et al., 2014). 
However, there has been little focus on the nature of anxiety experienced by parents 
or predictors of psychological wellbeing. Better understanding of the nature of 
anxiety experienced by parents of children with food allergies may help with the 
development of models and better treatment options for this population.  
 In qualitative research, parents of children with food allergy have described 
experiencing increased worry (e.g. Akeson, Worth, & Sheikh, 2007; Sanagavarapu, 
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Wainstein, Children, & Katelaris, 2016). Worry was also a common difficulty 
amongst participants in a recent case series study of cognitive behavior therapy 
(CBT) for parents of children with food allergies (Knibb, 2015), with a large 
proportion of participants scoring over the clinical cut-off for generalized anxiety 
disorder (GAD). It may be that parents identify more strongly with worry than other 
more somatic aspects of anxiety. However, larger studies assessing anxiety in parents 
of children with food allergy have typically used general measures (such as the 
HADS; Zigmond & Snaith, 1983), which are not suitable for exploring different 
forms of anxiety. This study will therefore include both a worry measure, and a 
measure of more physical symptoms of anxiety typical in panic presentations. 
Furthermore, both qualitative research (e.g Akeson et al., 2007; Rouf, White, 
& Evans, 2012) and a review of food allergy literature (Kelsay, 2003) have 
highlighted the need for post-traumatic stress symptoms (PTSS) to be investigated in 
parents of children with food allergies. Evidence of PTSS has also been found in 
parents of children with various other health conditions, including cancer (Kazak, 
Boeving, Alderfer, Hwang, & Reilly, 2005) and asthma (Kean, Kelsay, Wamboldt, 
& Wamboldt, 2006). Despite this, PTSS has remained unaddressed within food 
allergy literature. This study will therefore also assess whether parents report 
experiencing PTSS in relation to food allergy events.  
It is also important to consider factors that may predict psychological 
outcomes, as these can help both with the identification of more at risk parents and 
the development of psychological models and treatments. The majority of NICE 
recommended treatments for anxiety disorders are CBT-based (e.g. panic and GAD, 
NICE, 2011b; PTSD, NICE, 2018). There are common features across CBT-based 
anxiety disorder models, which are also incorporated in Clark and Beck's  (2010) 
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transdiagnostic cognitive model of anxiety. In particular, the nature of the anxiety-
provoking event, individuals’ perception of an event as threatening, and individuals’ 
perceived capacity to cope. As research examining the psychological impact of food 
allergies is in relative infancy, one factor from each of these three categories will be 
included in the present study. 
 Firstly, allergy severity, allergy factors have been included in some past 
research, with inconsistent findings. For example, Cummings, Knibb, Erlewyn-
Lajeunesse et al. (2010) found mothers of children at risk of anaphylaxis experienced 
significantly greater anxiety, whilst Marklund, Ahlstedt, and Nordström (2006) 
found the lowest emotional wellbeing in parents of children who primarily 
experience gastrointestinal symptoms, typically a less severe allergy. As the current 
study includes psychological outcomes that have not previously been assessed in this 
population, allergy factors will be retained despite these past mixed results. 
However, the study will also incorporate parental factors that may impact on 
perception of food allergies and their ability to cope, that have not received as much 
attention in past research, and may help to explain the inconsistencies in the previous 
literature. 
One belief that Clark and Beck (2010) propose can increase an individual’s 
perception of threat is intolerance of uncertainty. Intolerance of uncertainty is also 
suggested to be an important factor in individuals’ experience of worry (Dugas, 
Gosselin, & Ladouceur, 2001), and, as previously outlined, parents have described 
experiencing worry in relation to food allergy (Akeson et al., 2007; Sanagavarapu et 
al., 2016). Furthermore, in qualitative research, parents have described anxiety 
relating to the impossibility of completely controlling their child’s exposure to food 
allergens, and the associated need for calculated risk taking (Rouf et al., 2012). This 
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demonstrates the requirement for parents to frequently manage a degree of 
uncertainty relating to their child’s health, and therefore an intolerance of uncertainty 
may be particularly pertinent in this population.  
 Finally, parents’ food allergy related self-efficacy will be assessed, as a factor 
that may impact on their perceived ability to cope, which in turn would be expected 
to reduce anxiety (Clark & Beck, 2010). It has been suggested that self-efficacy 
could help to explain inconsistent results found between allergy severity and anxiety 
in past research, as parents of children with more severe allergies could receive more 
medical support or be more likely to develop family management plans (Cummings, 
Knibb, King, & Lucas, 2010). This may lead to greater confidence in food allergy 
management, in turn reducing anxiety. Providing parents with more knowledge, with 
a view to increasing confidence, has also been suggested as an intervention for 
improving parent wellbeing (Quach & John, 2018), it is therefore important to 
investigate whether a relationship between self-efficacy and psychological outcomes 
is found to support this recommendation. 
 In summary, this study aims to address significant gaps in the literature by 
investigating PTSS and the nature of anxiety experienced by parents of children with 
food allergy. The study will also contribute to the current understanding of 
psychological outcomes in this population by exploring three factors that may be 
expected to be related to parents’ experience of anxiety, worry and PTSS.  
 
Research Questions 
The present study has two primary research questions: 
1. Do parents of children with food allergy report clinically significant levels of 
worry, anxiety, and/or PTSS? 
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2. Are parents’ experiences of anxiety, worry and PTSS predicted by 
intolerance of uncertainty, food allergy self-efficacy, and/or severity of 
allergy? 
 
Method 
Design and Inclusion Criteria 
The study had a cross-sectional design using an online survey. Inclusion criteria were 
having main caring responsibility for a child (age 0-16 years) with a medically 
diagnosed food allergy. Participants were also required to be residents of the United 
Kingdom and to have sufficient understanding of English language to be able to 
complete the questionnaires. 
 
Procedure 
Ethical approval for the study was sought and granted by the NRES Committee East 
of England – Essex (Appendix D). 
Potential participants were invited to take part in a study investigating parent 
wellbeing in paediatric food allergy, with recruitment occurring through both social 
media advertisements and a paediatric allergy clinic. All participants completed the 
study online. Participants recruited through the allergy clinic were given information 
about the study (Appendix E) and completed a consent to contact form (Appendix F), 
which gave permission for the researcher to send potential participants two emails 
with information about the study and a link to the online survey. Social media 
advertisements were shared through Twitter and Facebook groups relevant to food 
allergy in the UK. 
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At the start of the online survey participants were given study information 
(Appendix G), asked to provide consent for participation (Appendix H), and 
informed of sources of further information and support for any issues raised in the 
study (Appendix I).  Participants then completed the questionnaires outlined below. 
At the end of the study participants were reminded of sources of further information 
and support (Appendix J), and had the opportunity to enter a prize draw to win one 
of ten £20 Amazon gift vouchers and to request a summary of the study’s results. 
 
Measures 
Demographic and allergy questions (Appendix K). For the purpose of the 
study a questionnaire was developed to gather information about the participant and 
their child(ren) with food allergy. Where participants had more than one child with 
food allergy, they were asked to complete the questions for each child. The 
questionnaire included five questions pertaining to the severity of each child’s food 
allergy: having an adrenaline auto-injector (AAI) prescribed, an AAI having been 
administered during an allergic reaction, history of anaphylaxis reaction, parent 
reported anaphylaxis symptoms (in line with action plans endorsed by the Royal 
College of Paediatrics and Child Health and the British Society for Allergy and 
Clinical Immunology, 2013), and having attended A&E with an allergic reaction. 
The questionnaire was developed based on past research and consultation with 
allergy clinicians.  
Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & 
Borkovec, 1990; Appendix L). The PSWQ is a 16-item measure of worry, scored 
on a five-point Likert scale. Total scores range from 16-80 (a higher score indicating 
greater levels of worry). The PSWQ has been found to have good reliability and 
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validity in both general and clinical populations, both for measuring worry as a 
transdiagnostic construct and for identifying GAD (Meyer et al., 1990; Brown, 
Antony, & Barlow, 1992) . As such, the PSWQ has two previously established cut-
offs, a score of 45 has been shown to discriminate clinical from non-clinical samples, 
whilst a score of 64 has been found to have discriminative validity for GAD 
compared to other anxiety and mood disorders (Behar, Alcaine, Zuellig, & 
Borkovec, 2003; Chelminski & Zimmerman, 2003). Within the current study 
Chronbach’s Alpha was 0.92, indicating good reliability. 
Depression Anxiety Stress Scales 21 (DASS-21) - Anxiety subscale 
(Lovibond & Lovibond, 1995; Appendix M). The DASS-21 anxiety subscale is a 
seven-item measure of anxiety experienced in the past week, predominantly focused 
on somatic symptoms. Responses are given on a four-point Likert scale, responses 
are totaled and doubled, resulting in a score from 0-42 with a higher score indicating 
greater anxiety. Based on a general population sample, five categories of scores have 
been developed to indicate increasing severity (Lovibond & Lovibond, 1995). In a 
large general population sample (Henry & Crawford, 2005), the DASS-21 anxiety 
subscale has been found to have good reliability and convergent validity with the 
anxiety subscale of the Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983). Within the current study Chronbach’s Alpha was 0.89, indicating 
good reliability. 
Impact of Events Scale – Revised (IES-R; Weiss & Marmar, 1997; 
Appendix N). The IES-R is a 22-item measure of trauma symptoms experienced 
over the past seven days, with responses scored on a five-point Likert scale, scores 
vary from 0-88 with a higher score indicating more trauma symptoms. A score of 33 
or more has been suggested to have the best diagnostic accuracy for PTSD (Creamer, 
60 
Bell, & Failla, 2003); however, a score of 24 or more has been suggested as 
indicative of clinically significant PTSS (Asukai et al., 2002). Participants were 
asked to complete the IES-R in reference to the most stressful experience they could 
recall related to their child’s allergy, and were asked to briefly indicate what this 
event was and when it occurred. The IES-R has been found to have good reliability 
(Weiss & Marmar, 1997), and has been used in much research exploring PTSS in 
parents of children with health conditions, including asthma (Kean et al., 2006). 
Reliability in the present study population was good, Chronbach’s alpha = 0.96.  
Intolerance of Uncertainty Scale – Short Form (IUS-S; Carleton, Norton, 
& Asmundson, 2007; Appendix O). The IUS-S is a 12-item measure of an 
individual’s attitudes towards uncertainty. The IUS-S is scored on a five-point Likert 
scale, with total scores ranging from 12-60, higher scores indicating less tolerance of 
uncertainty. The IUS-S has been found to have good reliability and validity in 
clinical and non-clinical samples (e.g. Khawaja & Yu, 2010).  
Food Allergy Self-Efficacy Scale for Parents (FASE-P; Knibb, Barnes, & 
Stalker, 2015). The FASE-P is a 21-item scale designed to measure parents’ 
confidence in managing their child’s food allergy. Parents rate their confidence in 
their ability to do each item from 0-100 (a higher score indicating greater 
confidence), an average confidence rating is then calculated. A score under 70 
indicates further support with allergy management is needed. The FASE-P’s 
psychometric properties have been assessed using an online survey of parents of 
children with food allergy, and found the scale to have good reliability and construct 
validity (Knibb et al., 2015).  
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Participants 
Parents. Participants were 106 parents (103 mothers, 3 fathers) who reported 
having a child(ren) with medically diagnosed food allergies. However, one mother 
was excluded from the analyses as no psychological outcome measures were 
completed. The age of the remaining 105 participants ranged from 23-55 years 
(mean=38.96, SD=6.53). Seventeen participants (16.2%) had more than one child 
with a medically diagnosed food allergy, of whom 16 had two children with food 
allergy and one had three children with food allergies. Ten participants (9.5%) also 
had a food allergy themselves.  
Participants predominantly found out about the study through social media 
advertisements (88.6%), with eight participants (7.6%) recruited through a paediatric 
allergy clinic, and 2.9% hearing about the study through other means (word of mouth 
and allergy charities). Consent to contact was taken from 13 parents at allergy 
clinics; however, no information is available for the number of eligible parents 
approached about the study. 
Children. The 123 children with food allergies reported on by parents were 
67 boys and 55 girls (1 gender not reported). Child age ranged from 6-months to 16 
years 10 months (mean=6.13years, SD=4.23). The most commonly reported food 
allergens were peanuts, milk, and egg, for all allergens see Table 5. The total number 
of different foods participants’ children were allergic to varied from 1-15 
(mean=4.07, SD=3.05).  
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Parents reported that their 
child’s food allergies had been 
diagnosed mainly by specialist allergy 
clinics (79.7%, N=98), but also GPs 
(7.3%, N=9), and other healthcare 
professionals including paramedics, 
dieticians, gastroenterologists, private 
consultants, general paediatricians, and 
dermatologists (13.0%, N=16). The 
method of diagnosis included skin 
prick testing (74.0%), medical history 
(56.1%), blood tests (42.3%), and 
other (primarily food challenges or 
elimination diets; 11.4%). 
Antihistamines had been 
prescribed for 85.4% (N=105) of 
children, and adrenaline auto-injectors 
(AAIs) for 67.5% (N=83). Sixty 
children (48.8%) had been taken to 
A&E because of an allergic reaction, 
with 50.4% reported to have 
experienced at least one anaphylactic reaction. Symptoms parents reported their 
children experiencing during an allergic reaction are displayed in Table 5. 
 
 
Table 5 
Child Food Allergy(s) and Symptoms Reported  
by Parents 
Allergen N 
Peanut 69 (56.1%) 
Milk 68 (55.3%) 
Egg 63 (51.2%) 
Tree Nut 53 (43.1%) 
Soy 28 (22.8%) 
Sesame 24 (19.5%) 
Wheat 21 (17.1%) 
Shellfish 8 (6.5%) 
Fish 6 (4.9%) 
Other 42 (34.2%) 
Symptom N 
Runny or congested nose 77 (62.6%) 
Bloated stomach 48 (39.0%) 
Abdominal pain 83 (67.5%) 
Diarrhoea 62 (50.4%) 
Vomitting 82 (66.7%) 
Hives or itchy skin rash 107 (87.0%) 
Itchy/tingling mouth 78 (63.4%) 
Persistent cougha 52 (42.3%) 
Swollen lips, face, or 
eyes 
84 (68.3%) 
Swollen tonguea 31 (25.2%) 
Difficulty swallowinga 37(30.1%) 
Breathing difficultiesa 51 (41.5%) 
Dizzinessa 31 (25.2%) 
Sudden tirednessa 54 (43.9%) 
Collapsea 20 (16.3%) 
Sudden change in 
behaviour 
56 (45.5%) 
aincluded as anaphylaxis symptom  
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Data Treatment 
Where parents had more than one child with food allergy, the five dichotomous 
allergy severity factors were included as ‘yes’ if at least one child met the criteria. 
An approximate median split was used to dichotomise anaphylaxis symptoms, 
resulting in a cut-off of having at least one child with at least three anaphylaxis 
symptoms. Where dummy coding of dichotomous variables was required for 
analyses, 0 represented ‘no’ and 1 represented ‘yes’. 
Missing Data. One participant was excluded from the PTSS analyses, as the 
event they answered the IES-R in relation to was not food allergy related. As the 
PSWQ, IES-R, and DASS-21 Anxiety Subscale were all found to be reliable, and 
there were no notable patterns in missing data (e.g. more sensitive questions being 
missed), individual mean substitution was used up to a maximum of 30% of missing 
items. This approach has been found to lead to less distortion of the dataset than 
alternative methods of missing data imputation, while minimizing data wastage 
(Roth, Switzer, and Switzer, 1999). Less than 1% of data was replaced using this 
approach. There was no missing data for the IUS-S or FASE-P.  
 
Data Analysis 
Data analysis was conducted using IBM SPSS Statistics v25. Regression analyses 
were used to address the second research question, for the PSWQ the assumptions of 
multiple linear regression were adequately met. However, for the DASS-21 and IES-
R linear regression assumptions were violated, therefore logistic regression was used 
for these two analyses. For the IES-R the data was split using the PTSS cut-off score 
of 24. As the DASS-21 uses five levels of severity rather than a single cut-off the 
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data was split into scores indicating no-mild anxiety (scores of 0-9) or moderate-
extremely severe anxiety (scores of 10-42). 
 As five dichotomous indicators of food allergy severity were included in the 
current study, initially differences in the three mental health outcome measures were 
assessed (using t-tests or non-parametric alternatives) with the aim of using the 
strongest predictors in the main regression analysis. Where more than one allergy 
severity variable was found to be significant, the relationship between these variables 
was explored further to assess whether they would offer unique contributions to a 
multiple regression model. 
Regression analyses were run including food allergy severity variable(s) at 
step 1, and parent self-efficacy (FASE-P) and intolerance of uncertainty (IUS-S) in 
step 2 of the models. Due to the small number of fathers who completed the study, it 
was not possible to control for gender in the analysis, regression analyses were 
therefore re-run excluding male participants, and controlling for maternal age. 
 
Results 
Do Parents of Children with Food Allergy Report Clinically Significant Levels 
of Worry, Anxiety, and/or PTSS? 
On the PSWQ, the mean score was 56.77(SD=12.69), 85 parents (81.0%) scored 
over the cut-off of 45 (found to distinguish clinical to non-clinical samples), and 37 
parents (35.2%) scored above 64 (found to have good discriminatory validity for 
generalized anxiety disorder). On the DASS-21 Anxiety Subscale, the mean score 
was 9.42(SD=9.54), 46.7% showed ‘normal’ levels of anxiety, 14.3% ‘mild’, 14.3% 
‘moderate’, 8.6% ‘severe’, and 16.2% ‘extremely severe’. On the IES-R, the mean 
score was 22.28(SD=20.34), 44 parents (42.3%) scored above 24, the recommended 
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cut-off for clinically significant PTSS, with 33.7% (N=35) scoring over 33, the 
suggested clinical cut-off for PTSD. The stressful events reported by parents for the 
IES-R included witnessing anaphylactic reactions in their child (51.0%), witnessing 
non-anaphylactic allergic reactions in their child (39.4%), and other events (9.6%) 
such as hearing about an allergic reaction in their child or finding out their child was 
exposed to allergens. This was similar amongst parents who scored over the cut-off 
for PTSS (56.8% anaphylaxis, 36.4% non-anaphylactic allergic reaction, and 6.8% 
other). For parents who reported clinically significant PTSS, time since the traumatic 
event varied from less than one week to ten years, with a median of 11 months. 
Overall, 86.7% of participants reached the clinical cut-off on at least one of 
the three psychological outcome measures, with 48.6% showing clinical significant 
levels on at least two measures, and 25.7% reaching the clinical threshold on all three 
psychological outcome measures. 
 
Are Parents’ Experiences of Worry, Anxiety, and PTSS Predicted by 
Intolerance of Uncertainty, Food Allergy Self-Efficacy, and/or Severity of 
Allergy? 
 Greater intolerance of uncertainty and lower food allergy self-efficacy were 
significantly correlated with anxiety, worry, and post-traumatic stress symptoms 
(Table 6); however the correlations were consistently stronger for intolerance of 
uncertainty.  
 
Differences in worry, anxiety, and trauma symptoms between food allergy 
severity groups are shown in Table 7. A significant difference in anxiety, worry and 
PTSS was observed for parent reported anaphylaxis symptoms, a significant 
difference in worry and PTSS was also observed for an AAI having been 
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administered, and in PTSS for A&E having been attended for an allergic reaction. 
Whilst the relationship between the significant allergy severity variables did not 
appear strong enough to warrant concerns of multicollinearity (Cramer’s phi=0.31-
0.41), inclusion of multiple allergy factors in regression analyses appeared to mask 
the effect of the individual variables. Further exploration indicated that this appeared 
to be due to an AAI having been administered mediating the relationship between 
parent reported anaphylaxis symptoms and A&E attendance with worry and PTSS. 
As an AAI having been administered was also found to have the largest effect size 
for both worry and PTSS, a decision was made include an AAI having been 
administered as the only marker of allergy severity in worry and PTSS regression 
analyses. For the anxiety regression, parent reported anaphylaxis symptoms was 
included as the only severity marker found to have a significant difference. 
 
 
Table 6 
Mean Scores and Correlations Between Intolerance of Uncertainty, Food Allergy 
Self-Efficacy, Worry, Anxiety, and Post-Traumatic Stress Symptoms  
 Mean(SD) 1 2 3 4 5 
1. IUS-S 34.30(10.66) -     
2. FASE-P 72.11(14.10) -.42**a -    
3. PSWQ 56.76(12.63) .66**a -.22*a -   
4. DASS-21 
Anxiety Subscale 
9.50(9.53) .45** -.24* .51** -  
5. IES-R 22.28(20.34) .47** -.33** .37** .58** - 
Note. IUS-S = Intolerance of Uncertainty Scale – Short Form; FASE-P = Food 
Allergy Self-Efficacy Scale for Parents; PSWQ = Penn State Worry Questionnaire; 
DASS-21 = Depression Anxiety Stress Scales 21; IES-R = Impact of Events Scale 
Revised.  
aPearson’s correlation coefficient, all other correlations using non-parametric 
Spearman’s rank correlation coefficient 
*p<.05  **p<.01 
 
 
 Table 7 
Differences in Worry, Anxiety, and Post-Traumatic Stress Symptoms in Parents Whose Children do and do not Have Indicators of More Severe 
Food Allergies	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. PSWQ = Penn State Worry Questionnaire; DASS-21 = Depression Anxiety Stress Scales 21; IES-R = Impact of Events Scale Revised; 
AAI prescribed = At least one child with an adrenaline auto-injector prescribed for food allergy; AAI Given = AAI administered at least once 
during an allergic reaction; Anaphylaxis History = At least one previous parent-reported anaphylactic reaction to food; A&E attended = Accident 
and Emergency attended at least once due to food allergy; Anaphylaxis Symptoms = Parent reports having at least one child who has experienced 
at least three symptoms indicative of anaphylaxis during allergic reactions. 
aindependent samples t-test  bMann-Whitney U test 
 
 
   PSWQ DASS-21 Anxiety IES-R 
  N Mean(SD) pa Mean(SD) pb Mean(SD) pb 
AAI 
Prescribed 
Yes 78 57.90(11.27) .191 9.43(9.62) .751 23.48(21.09) .545 
No 26 53.38(16.00) 9.92(9.54) 19.20(18.24) 
AAI Given Yes 21 61.76(11.85) .042* 11.71(10.03) .134 36.29(19.16) <.001** 
No 84 55.51(12.57)  8.94(1.23)  18.74(19.16) 
Anaphylaxis 
History 
Yes 60 57.54(11.74) .467 10.34(1.33) .315 23.97(20.87) .476 
No 45 55.72(13.78) 8.23(1.23) 20.07(19.64) 
A&E 
Attended 
Yes 57 56.96(12.49) .923 10.79(10.10) .189 27.33(21.65) .022* 
No 47 56.72(12.97)  8.05(8.73)  16.75(17.11)  
Anaphylaxis 
Symptoms 
Yes 45 59.81(11.43) .031* 12.29(10.91) .020* 29.36(23.40) .016* 
No 60 54.48(13.08) 7.41(7.79) 17.09(16.07) 
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Worry. Hierarchical multiple regression was used to predict parental worry (PSWQ 
score), with an AAI having been administered at the first step, and food allergy self-
efficacy (FASE-P) and intolerance of uncertainty (IUS-S) entered at step 2. The first 
model was significantly predictive of parental worry, F(1,103) = 4.25, p=.042, but 
explained only 4.0% of variance. When self-efficacy and intolerance of uncertainty 
were added to the model, it remained significantly predictive of worry, F(3,101) = 
29.66, p<.001, and was a significantly better fit of the data, ΔF(2,101)=40.74, 
p<.001. The second model explained an additional 42.9% of variance. Within this 
model, an AAI having been administered and intolerance of uncertainty were 
significant predictors of worry, but food allergy self-efficacy was not (Table 8), the 
strongest predictor in the model was intolerance of uncertainty (β = .69). This pattern 
of results was maintained when fathers were excluded from the analysis, but when 
controlling for maternal age only intolerance of uncertainty remained a significant 
predictor. 
 
Table 8 
Hierarchical Multiple Regression Model for Parental Worry (PSWQ) 
 B SE B β p 
Step 1 (R2=.04)     
AAI given 6.25 3.03 .20 .042* 
Constant 55.51 1.36  <.001** 
Step 2 (R2=.47)     
AAI given 4.79 2.29 .15 .038* 
IUS-S 0.81 0.10 .69 <.001** 
FASE-P 0.07 0.07 .08 .316 
Constant 22.71 7.25  .002* 
Note. AAI Given = Adrenaline auto-injector administered at least once during an 
allergic reaction; IUS-S = Intolerance of Uncertainty Scale – Short Form; FASE-P = 
Food Allergy Self-Efficacy Scale for Parents.  
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Anxiety. Binary logistic regression was used to predict parental anxiety (no-
mild or moderate-extremely severe anxiety on the DASS-21 Anxiety Subscale). The 
first model, including only parent reported anaphylaxis symptoms, did not lead to a 
significant improvement in the classification of clinical cases, χ2(1) = 3.20, p=.074. 
When intolerance of uncertainty and food allergy self-efficacy were added to the 
model, there was a significant improvement in the number of participants correctly 
classified, χ2(3)=12.65, p=.005. A Hosmer and Lemeshow Test indicated that the 
model was a good fit of the data, χ2(8) = 6.99, p=.538. Within this model, intolerance 
of uncertainty was the only variable that was individually significantly predictive 
(Table 9). The model correctly classified 69.5% of participants, with superior 
specificity than sensitivity (Table 10). When fathers were excluded from the analysis 
and controlling for maternal age, intolerance of uncertainty remained the only 
individually significant predictor of anxiety. 
 
 
Table 9 
Logistic Regression Model of Anxiety in Parents of Children with Food Allergies 
 
Predictor β SE β p OR (eβ) [95% 
confidence intervals] 
Step 1     
Anaphylaxis 
Symptoms 
-.73 .41 .075 0.484 [0.22, 1.10] 
Constant -.04 .30 .882 0.96 
Step 2     
Anaphylaxis 
Symptoms 
-.78 .43 .073 0.46[0.20, 1.08] 
IUS-S .05 .02 .031* 1.05[1.01, 1.10] 
FASE-P -.02 .02 .320 0.98[0.95, 1.02] 
Constant -0.53 1.72 .759 .589 
Note. Anaphylaxis Symptoms = Parent reports having at least one child who has 
experienced at least three symptoms indicative of anaphylaxis during allergic 
reactions; IUS-S = Intolerance of Uncertainty Scale – Short Form; FASE-P = Food 
Allergy Self-Efficacy Scale for Parents. 
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Table 10 
Classification Table for Logistic Regression Model of Anxiety 
Observed Predicted Percentage Correct 
 No-Mild 
Anxiety 
Moderate-
Severe Anxiety 
 
No-Mild Anxiety 54 10 84.4 
Moderate-Severe Anxiety 22 19 46.3 
Overall Correct   69.5 
 
 
PTSS. Binary logistic regression to predict whether parents experienced 
clinically significant PTSS symptoms (i.e. IES-R above 24), found a model including 
only an AAI having been administered led to a significant improvement in the 
classification of clinical cases, χ2(1) = 12.53, p<.001. However, when intolerance of 
uncertainty and food allergy self-efficacy were added to the regression model, there 
was a significant improvement in the number of participants correctly classified, 
χ2(3)=31.24, p<.001, and a Hosmer and Lemeshow test indicated the model was a 
good fit of the data,  χ2(8) = 8.29, p=.406. Within this model an AAI having been 
administered and intolerance of uncertainty were individually significantly predictive 
of PTSS (Table 11). The model correctly classified 76.9% of participants, although 
the model’s specificity was superior to its sensitivity (Table 12). This pattern of 
results was maintained when removing fathers from the analysis, and controlling for 
maternal age. 
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Table 11 
Logistic Regression Model of PTSS in Parents of Children with Food Allergies 
 
Predictor β SE β p OR (eβ) [95% 
confidence intervals] 
Step 1     
AAI given -1.84 .56 .001** 0.16 [0.05, 0.48] 
Constant 1.16 .51 .023* 3.20 
Step 2     
AAI given -2.00 .61 .001** 0.14 [0.04, 0.45] 
IUS-S .07 .03 .006** 1.07 [1.02, 1.13] 
FASE-P -.03 .02 .089 0.97 [0.94, 1.00] 
Constant 1.04 1.87 .579 2.82 
Note. AAI Given = Adrenaline auto-injector administered at least once during an 
allergic reaction; IUS-S = Intolerance of Uncertainty Scale – Short Form; FASE-P = 
Food Allergy Self-Efficacy Scale for Parents.  
 
 
Table 12 
Classification Table for Logistic Regression Model of PTSS 
 
 
Observed 
 
 
Predicted 
 
 
Percentage Correct 
 IES-R below 24 IES-R above 24  
IES-R below 24 50 10 83.3 
IES-R above 24 
 
14 30 68.2 
Overall Correct   76.9 
Note. IES-R = Impact of Events Scale – Revised.  
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Discussion 
This study found a large proportion of parents of children with food allergies 
reported clinically significant worry, anxiety, and/or PTSS. This varied from 39.0% 
of participants reporting moderate-extremely severe anxiety (DASS-21 Anxiety 
Subscale) to 81.0% of parents reporting clinically significant worry (PSWQ). 
Clinically significant levels of PTSS were observed in 42.3% of participants, 
including parents of children with both life-threatening and milder allergies. Within 
regression analyses, greater intolerance of uncertainty was a consistent significant 
predictor of worry, anxiety, and PTSS. In contrast, whilst food allergy self-efficacy 
was significantly correlated with all three mental health outcome measures, it did not 
remain significant in any of the planned regression analyses. Finally, mixed results 
were found for the relationship between allergy severity and parent mental health.  
These findings supplement previous qualitative studies in the field, which 
have indicated worry (e.g. Akeson et al., 2007; Sanagavarapu et al., 2016) and 
trauma symptoms (e.g. Akeson et al., 2007; Rouf et al., 2012) in parents of children 
with food allergy. The rates of anxiety found in the current study, are also 
comparable to past research that has used general measures of anxiety, such as the 
HADS (e.g. Knibb & Semper, 2013). However, the disparity between the rates of 
clinically significant anxiety and worry found in the present study highlight the 
benefit of considering different types of anxiety rather than exploring anxiety as a 
unitary construct.  
The strong relationship found between intolerance of uncertainty and mental 
health outcomes is congruent with the high rates of worry in the sample, a 
presentation where intolerance of uncertainty has been suggested to play a central 
role (Dugas et al., 2001). This finding is also in keeping with qualitative parent 
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reports (e.g. Rouf et al., 2012) and the nature of food allergy, due to the impossibility 
of guaranteeing non-exposure to allergens.  However, contrary to anxiety models 
(Clark & Beck, 2010), and suggestions in past research (e.g. Quach & John, 2018), 
food allergy self-efficacy was not a significant predictor in any of the regression 
analyses. It may be that parents’ perception of threat was too great to be moderated 
by their confidence in allergy management. This is an important clinical finding, as 
whilst confidence is important for medical management, the present study indicates 
that psychological interventions may be more effective if they focus on factors that 
impact on parents’ threat perception (e.g. intolerance of uncertainty). 
The mixed results for allergy severity are also in keeping with the previous 
literature (e.g. Cummings, Knibb, Erlewyn-Lajeunesse et al., 2010; Marklund et al., 
2006); however, the study raised interesting novel findings particularly for having an 
AAI administered, which was a significant predictor of worry and PTSS. While an 
AAI having been administered has been discussed in some previous research (e.g. 
Ogg, Wong, Wan, Davis, & Arkwright, 2017; Williams, Parra, & Elkin, 2009), it has 
been considered less frequently than an AAI having been prescribed, particularly in 
relation to anxiety. In the wider paediatric psychology literature, parents of children 
with Type I diabetes have reported giving injections to be the second most 
distressing diabetes related event, with the most distressing being having their child 
rushed to hospital (Horsch, McManus, Kennedy, & Edge, 2007). Given AAI 
administration involves giving an injection during a potentially life-threating 
reaction, likely to lead to A&E admission, it is in keeping with this research that 
parents may find this particularly distressing. If this finding is supported by future 
research, it may be beneficial to introduce targeted brief psychological assessments 
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for parents whose children have had an AAI administered; however, at this stage 
caution is needed due to the limitations of the current study. 
Firstly, the study used a cross-sectional design, and therefore it is not possible 
to establish causality between food allergy and psychological outcomes. Whilst 
PTSS was measured in relation to the most stressful food allergy event parents could 
recall, inferring a degree of causality, the time since this event took place was not 
controlled for and as the IES-R only considers symptoms over the past week it does 
not account for the potential of resolved PTSS. It would be beneficial for future 
research to take a longitudinal approach, better suited to establishing causality 
between food allergy events and psychological distress.  
A further limitation of the study is the gender split of participants. While 
inclusion criteria were any adult with the main caring responsibility for a child with 
food allergy, only three fathers participated. In the future, a paired design may be 
helpful allowing both parents to report. This may be more feasible using clinic based 
recruitment, which would also be better suited to drawing conclusions on prevalence, 
as it is more possible to assess the representativeness of the study sample. 
Finally, while the regression models in the present study were significant, a 
large proportion of variance in psychological outcomes remained unexplained. 
Whilst this is to be expected, it could be beneficial for future research to include 
alternative predictors that were not assessed in the present study. In particular, given 
the positive findings for intolerance of uncertainty, it may be beneficial to examine 
additional parental factors that influence threat perception (e.g. food allergy related 
locus of control, or attitudes towards risk). A better understanding of these factors, 
could help lead to the development of a psychological model for the impact of food 
allergy, which in turn could guide treatment. 
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Despite its limitations, this study addresses a significant gap in the literature 
through assessing PTSS in parents of children with food allergies, a need highlighted 
in a 2003 review (Kelsay, 2003) that had remained unaddressed. The study also 
considered different types of anxiety, and to the best of the authors’ knowledge was 
the first study to include a worry specific measure in a large study within this 
population.  The differences in prevalence and regression results between the three 
mental health outcomes highlight the utility of taking this approach. This may help to 
explain inconsistent findings in past research, which has typically used general 
measures of anxiety (e.g. the HADS), which may have masked different patterns of 
psychological response. The study also provides useful information for the 
development of models and the psychological treatment of anxiety and PTSS in 
parents of children with food allergy, through highlighting a strong relationship 
between intolerance of uncertainty and greater psychological distress in this 
population. Overall, the study highlights the importance of greater awareness of 
parents’ mental health in paediatric food allergy, and offers direction for future 
research in this comparatively new field. 
 
Acknowledgements: With thanks to Dr Alex Brightwell for advising on the 
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Chapter 4: Extended Methodology 
 
The following chapter provides additional information concerning the methodology 
of the empirical research paper, including ethical considerations, the allergy 
demographic questionnaire, and power analysis. 
 
Ethical Considerations 
Public and Patient Involvement 
Prior to the application for ethical approval feedback on both the ethics 
application and participant facing documents was sought from a parent of a child 
with allergies through a public and patient involvement group (PPIRes). Revisions 
were made in response to this feedback, for example the inclusion of support 
information at the start as well as the end of the survey. 
 
Clinic Recruitment 
The decision for clinic recruitment to involve consent to contact, rather than 
allowing full consent and participation at clinic appointments, was both ethical and 
methodological. Ethically, the decision was made to reduce the risk of coercion, as it 
was not possible to inform potential participants about the project in advance of their 
clinic appointments, to allow greater time to consider participation. 
Methodologically, it also allowed all participants to complete the survey in the same 
format, to reduce methodological differences that may impact responses. 
Participants who were recruited through the paediatric allergy clinic were 
initially approached by a member of the allergy team. When the researcher was not 
present, the allergy team would briefly introduce the project, provide the information 
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sheet, and if interested ask the potential participant to complete the consent to contact 
form.  When the researcher was available in clinic, potential participants gave verbal 
consent to the food allergy team to speak to the researcher about the project. The 
researcher then discussed the project, answered any questions, and if interested 
provided the participant with an information sheet (Appendix E) and consent to 
contact form to complete (Appendix F). In all instances, consent to contact forms 
were transported in a locked case, and subsequently stored in a locked cabinet at the 
University of East Anglia. 
 
Confidentiality 
The survey was completed anonymously, which helps maintain participant 
confidentiality. However, due to this it was not possible to follow-up with 
participants who scored highly on any of the measures of psychological distress. All 
participants were therefore signposted to sources of information and were advised to 
contact their GP if they felt they would benefit from additional support with any of 
the issues raised in the study. In response to PPI feedback, participants were also 
advised to complete the survey at a time when they had support available if they felt 
the topics covered in the research could be distressing for them.  
 The only identifiable information collected during the online survey was for 
the purpose of administering the prize draw and the option for participants to receive 
a summary of the results of the study. Bristol Online Surveys was used to host the 
survey, which is compliant with UK and EU data protection laws, including the 
updated General Data Protection Regulations (GDPR; Regulation (EU) 2016/679). 
The survey data was downloaded on the university server and identifiable 
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information was immediately removed and saved in separate password protected 
spreadsheets.  
 
Prize draw 
Within the budget of the thesis and recruitment targets, it was not possible to 
reimburse all participants. A decision was made to offer a prize draw as a token of 
appreciation for participation. Multiple smaller prizes were offered rather than one 
large prize, as this was considered less coercive and allowed a greater proportion of 
participants to receive a prize. To ensure the prizes were fairly distributed, all 
participants that chose to enter the prize draw were allocated a participant number, 
and a random number generator was used to select prize draw winners. The winners 
were emailed, and it was explained that if no response was received within three 
weeks the prize would be reallocated, using the same process. 
 
Demographic and Allergy Questionnaire 
The questionnaire regarding the participants’ child(ren) and their allergy was 
developed on the basis of past research, and discussion with an allergy paediatrician 
(AB) and the primary supervisor (JY) who has clinical psychology experience 
working with food allergy.  
Although specific food allergies are usually not hereditary, there is evidence for a 
genetic propensity towards allergic conditions (Marenholz et al., 2017), and it was 
therefore considered particularly important to account for the fact that parents may 
have more than one child with food allergy. Different approaches to manage this 
were considered. No strong rationale was apparent for asking parents to respond in 
relation to a particular child, a decision was therefore made to allow parents to 
84 
respond in relation to multiple children with food allergy. This provided more 
detailed information, and allowed the researchers to make the decision on 
assimilating this during the results. In particular, if any allergy variable were a risk 
factor for poorer psychological wellbeing in parents, one would expect to observe 
this if any of their children shared this allergy characteristic or experience, asking 
parents to respond in relation to a specific child risked losing some of this 
information. 
 
Power Analysis 
A priori power analyses were conducted to determine recruitment targets. On the 
basis of a multiple regression with three predictors (intolerance of uncertainty, food 
allergy self-efficacy, and allergy severity), with a medium effect size and alpha level 
of .05, G*Power (Erdfelder, Faul, Buchner, & Lang, 2009) generates a target sample 
size of 77 (for power at the 0.8 level). Alternatively, using Green's (1991) rule of 
thumb for regression analyses, a sample size of 74 would be considered necessary 
with a sample of 107 preferable for also considering the contribution of individual 
predictors. If all five allergy severity factors were included in regression analyses 
(total of seven predictors), G*Power recommends a sample size of 103. Recruitment 
targets were set for this range, and the study successfully recruited to the upper end 
of this target allowing more power and flexibility in the analyses.  However, due to 
assumption violations, logistic rather than multiple regression was used for some 
analyses. There is a lack of clear consensus regarding the most appropriate approach 
for calculating necessary sample sizes for logistic regression analyses (e.g. 
Demidenko, 2006); however, as the models in the main paper were significant it can 
be assumed that the study was sufficiently powered.   
85 
Chapter 5: Extended Results 
 
The following chapter provides additional results for the empirical research project: 
firstly, outlining the statistical assumptions that were checked and where these were 
violated; secondly, providing additional information regarding the decision of which 
allergy severity factors were included in the main regression analyses; and finally 
presenting an exploratory analysis to evaluate additional demographic and allergy 
variables that may predict psychological outcomes. 
 
Statistical Assumptions 
Multiple linear regression is dependent on the following statistical assumptions being 
met (the approach used to test each assumption is included in brackets): normal 
distribution of the standardized residuals (visual inspection of histogram), absence of 
outliers/points having an undue influence on the regression line (large standardized 
residuals, Cook’s distance values), homoscedasticity (inspection of scatter plot of 
standardized residuals against standardized predicted values), absence of 
multicollinearity (size of relationship between predictor variables), no indications of 
a non-linear relationship between continuous predictor and outcome variables 
(inspection of scatterplots). For the worry regression analysis each of these 
assumptions were adequately met.    
 Neither the IES-R (PTSS measure; Weiss & Marmar, 1997) nor the DASS-21 
Anxiety Subscale (Lovibond & Lovibond, 1995) were normally distributed, with the 
former approaching a bimodal distribution with a positive skew (Figure 3) and the 
latter showing a positive skew (Figure 4). Whilst non-normally distributed outcome 
variables are not always inherently problematic in regression analyses, it can be more 
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likely that the main statistical assumptions are violated. This was the case in the 
empirical paper analyses, where plots to assess homoscedasticity for both PTSS and 
anxiety showed a cone/wedge shape, indicating the data to be heteroscedastic (Clark-
Carter, 2010).  There are two main alternatives to managing this form of assumption 
violation: use a data transformation or use an alternative statistical test.   
While performing data transformations can allow the planned statistical 
analysis to be conducted, it can also lead to the results being less clearly 
interpretable, and where the assumption violations are caused by what could be 
considered meaningful patterns in the data, rather than spurious results of a particular 
sample, important results and meaning can be lost. This is notable in the case of 
PTSS, where one could theoretically predict to see a bimodal distribution, as a large 
proportion of the population would not be expected to experience PTSS, but a more 
normal distribution could be expected amongst those scoring in the clinical range 
(i.e. in those who are experiencing distress in relation to a traumatic event). This is 
broadly what can be observed in the histogram of PTSS scores in the present sample 
(Figure 3), and it is particularly notable that the dip in the distribution approximately 
coincides with the previously established PTSS cut-off score of 24 (Asukai et al., 
2002). As such, even if statistical assumptions could be met through data 
transformation, multiple linear regression would mask this data pattern and the 
results could therefore be considered to have less explanatory power. It was therefore 
considered more appropriate to use logistic regression for these analyses. There is a 
less clear rationale for preferring data transformation or logistic regression for 
anxiety, as theoretically anxiety could be expected to approximate a normal 
distribution. However, as transformed data is less immediately interpretable, and 
would have resulted in using a different analytic approach for all three psychological 
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outcomes (which in turn makes comparisons across models more difficult), it was 
considered more appropriate to also use logistic regression for this analysis. 
Logistic regression has fewer statistical assumptions than multiple linear 
regression, but still requires variables to be independent of each other, a lack of 
multicollinearity, and a linear relationship between the predictors and log odds 
(tested using the Box-Tidwell method; Osborne, 2015). All of these assumptions 
were met for the anxiety and PTSS analyses.  
 
 
 
Figure 3. Histogram showing parents’ PTSS scores. 
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Figure 4. Histogram showing parents’ anxiety scores. 
 
Relationship Between Allergy Severity Variables 
As outlined in the previous chapter, prior to conducting regression analyses, the 
relationships between the significant allergy severity factors were assessed to check 
for potential issues with multicollinearity. For worry this included parent reported 
anaphylaxis symptoms and an AAI having been administered, and for PTSS this 
included these two variables as well as A&E having been attended for an allergic 
reaction. As the effect size of the relationship between these variables did not present 
cause for concern (largest Cramer’s Phi = 0.41), initially regression analyses were 
conducted including all significant severity factors for each psychological outcome. 
However, when multiple allergy severity factors were included in a regression 
model, no variable remained individually significantly predictive, and as this was not 
readily explained by collinearity it raised concern of possible interaction effects, 
which could mask the contribution of allergy severity in the final analyses. As such, 
possible moderations and mediations that were considered to make clinical and 
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theoretical sense were explored, which indicated that an AAI having been 
administered may mediate the relationship between the remaining allergy severity 
factors and psychological outcomes.  
As all allergy severity variables as well as PTSS were dichotomous variables, 
the syntax and spreadsheet developed by Herr (n.d.) was used to conduct the 
mediation analyses which calculates the proportion of effect mediated based on 
Mackinnon and Dwyer's (1993) methodology. For PTSS, an AAI having been 
administered mediated 63.9% of the relationship between A&E attendance and 
PTSS, and 58.5% of the relationship between anaphylaxis symptoms and PTSS. The 
mediation effect for worry was smaller, with an AAI having been administered 
explaining 29.8% of the relationship between anaphylaxis symptoms and PSWQ 
score. While much smaller, this mediation is still accounting for a notable proportion 
of the relationship between anaphylaxis symptoms and worry. An AAI having been 
administered also showed a larger effect size for difference in worry than 
anaphylaxis symptoms. It was therefore considered most appropriate to include only 
an AAI being administered in the worry and PTSS analyses.  
As an additional check that overall explanatory power was not being lost 
through the omission of the additional severity variables, a comparison was made in 
the total variance explained in worry and PTSS regression models including all 
significant allergy severity variables and those including only an AAI having been 
administered. For worry, the additional inclusion of anaphylaxis symptoms explained 
an additional 1% of variance, and for PTSS the inclusion of anaphylaxis symptoms 
and A&E attendance improved classifications by 1.7%. As this represents only a 
very small overall improvement, and the significance of the individual variables is 
lost, the model including only one severity variable was considered to have the best 
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explanatory power whilst also minimizing the risk of over fitting the regression 
models. 
 
Exploratory Data Analysis 
Given the early stage of research in this field, an additional exploratory analysis was 
conducted to include additional allergy and demographic factors, with a view to 
guiding future research. For this exploratory analysis, all possible variables were 
analysed against the three mental health outcomes (anxiety, worry, and post-
traumatic stress), using correlations for continuous variables, and t-tests or non-
parametric alternatives for dichotomous variables. Regression analyses were then re-
run including all variables that showed a significant relationship, with 
demographic/allergy factors included in step 1, and parent factors added in step 2. As 
the purpose of this additional analysis is to guide future research, rather than draw 
firm conclusions, no steps were taken to account for multiple testing, as in the 
context of an exploratory analyses this can be overly harsh and result in overlooking 
potentially valuable results (e.g. Althouse, 2016). 
 
Data Treatment 
Where parents had more than one child with food allergy, child age was 
averaged, total number of different food allergens was summed, and dichotomous 
items (e.g. whether an AAI was prescribed) were included as ‘yes’ if at least one 
child met the criteria (as per main analysis). For analyses including child gender, 
parents were excluded if they had both male and female children with food allergies. 
Anaphylaxis symptoms were included as per the main analysis, but two further 
groups of allergy symptoms were explored. Firstly, mild-moderate symptoms, i.e. 
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symptoms not considered to be indicative of anaphylaxis (British Society for Allergy 
and Clinical Immunology, 2013). Secondly, gastrointestinal symptoms (bloated 
stomach, abdominal pain, diarrhea, vomiting), these form a subset of the mild-
moderate symptoms that have previously been suggested to be particularly 
concerning for parents (Marklund, Ahlstedt, & Nordström, 2006). An approximate 
median split resulted in a cut-off of having at least one child with at least six mild-
moderate symptoms or three gastrointestinal symptoms.  
 
Results 
Table 13 shows the correlations between all continuous variables and the 
three mental health outcome measures, with Table 14 showing the results of between 
group comparisons for dichotomous variables and mental health outcomes. The 
significant variables for each mental health measure were then included in regression 
analyses; however, as per the regression analyses presented in the empirical paper, 
due to relationships between the different measures of allergy severity, parent 
reported anaphylaxis symptoms were omitted from the worry and PTSS analyses, 
and A&E attendance was also excluded from the PTSS analysis. Furthermore, as 
gastrointestinal symptoms formed a subset of the mild-moderate symptoms these 
variables could not be considered independent. As such, only gastrointestinal 
symptoms were included in regression analyses as the effect size was larger for this 
variable suggesting it to be a stronger predictor.
 Table 13 
Correlations Between All Continuous Variables Assessed in Empirical Study 
 1 2 3 4 5 6 7 8 9 10 
1. Child Age -          
2. Parent Age .69** -         
3. Number of Food 
Allergies 
-.07 .001 -        
4. Time for Diagnosis -.02 -.07 .27** -       
5. Time Since Diagnosis .88** .64** .05 -.07 -      
6. IUS-S -.03 -.19a .07 .23* -.08 -     
7. FASE-P .25* .29** -.001 -.08 .23* -.44** -    
8. PSWQ .09 -.01a .13 .10 .07 .66**a -.22* -   
9. DASS-21 Anxiety 
Subscale 
.09 -.04 .19 .22* .16 .45** -.24* .51** -  
10. IES-R -.01 -.12 .14 .12 -.03 .47** -.33** .37** .58** - 
Note. IUS-S = Intolerance of Uncertainty Scale – Short Form; FASE-P = Food Allergy Self-Efficacy Scale for Parents; PSWQ = Penn State 
Worry Questionnaire; DASS-21 = Depression Anxiety Stress Scales 21; IES-R = Impact of Events Scale Revised. 
aPearson’s correlation coefficient, all other correlations using non-parametric Spearman’s rank correlation coefficient 
*p<.05  **p<.01 
 
 
 
 
 Table 14 
Differences in Worry, Anxiety, and PTSS Scores with all Possible Dichotomous Demographic and Allergy Variables 
   PSWQ DASS-21 Anxiety IES-R 
  N Mean(SD) pa Mean(SD) pb Mean(SD) pb 
Child Gender Male 50 55.44(13.29) .580 10.25(11.32) .828 25.56(23.24) .373 
Female 42 56.95(12.66) 7.93(7.50) 18.83(18.23) 
Other health 
condition 
Yes 87 57.13(11.95) .518 9.53(9.37) .891 23.00(20.03) .227 
No 18 55.00(15.76) 9.35(10.55) 18.84(22.02) 
More than one child 
with food allergy 
Yes 17 58.18(10.22) .616 10.24(7.34) .289 23.41(16.37) .391 
No 88 56.49(13.07) 9.36(9.92) 22.06(21.10) 
AAI Prescribed Yes 78 57.90(11.27) .191 9.43(9.62) .751 23.48(21.09) .545 
No 26 53.38(16.00) 9.92(9.54) 19.20(18.24) 
AAI Given Yes 21 61.76(11.85) .042* 11.71(10.03) .134 36.29(19.16) <.001** 
No 84 55.51(12.57)  8.94(9.38)  18.74(19.16)  
Anaphylaxis History Yes 60 57.54(11.74) .467 10.34(1.33) .315 23.97(20.87) .476 
No 45 55.72(13.78) 8.23(1.23) 20.07(19.64) 
A&E Attended Yes 57 56.96(12.49) .923 10.79(10.10) .189 27.33(21.65) .022* 
 No 47 56.72(12.97)  8.05(8.73)  16.75(17.11)  
Anaphylaxis 
Symptoms 
Yes 45 59.81(11.43) .031* 12.29(10.91) .020* 29.36(23.40) .016* 
No 60 54.48(13.08) 7.41(7.79) 17.09(16.07) 
Mild-moderate 
symptoms 
Yes 58 56.82(11.73) .960 11.78(10.35) .007** 26.35(21.97) .049* 
No 47 56.69(13.78)  6.69(7.60)  17.35(17.13)  
Gastrointestinal 
Symptoms 
Yes 50 56.74(13.18) .987 12.78(10.55) .001** 27.82(22.25) .012* 
No 55 56.78(12.21) 6.51(7.40) 17.35(17.23) 
Parental Food 
Allergy 
Yes 10 55.50(11.57) .741 3.80(4.05) .045* 8.90(12.84) .016* 
No 95 56.89(12.78) 10.10(9.75) 23.71(20.52) 	 	
 Table 14 (Continued) 
Note. PSWQ = Penn State Worry Questionnaire; DASS-21 = Depression Anxiety Stress Scales 21; IES-R = Impact of Events Scale Revised;  
AAI prescribed = At least one child with an adrenaline auto-injector (AAI) prescribed for food allergy; AAI Given = AAI administered at least 
once during an allergic reaction; Anaphylaxis History = At least one previous parent-reported anaphylactic reaction to food; A&E attended = 
   PSWQ DASS-21 Anxiety IES-R 
  N Mean(SD) pa Mean(SD) pb Mean(SD) pb 
Currently taking 
mood medication 
Yes 10 63.70(12.23) .065 18.60(10.54) .001** 33.80(24.44) .050 
No 93 55.91(12.59) 8.10(8.50) 20.49(19.36) 
Food Allergens:         
Milk Yes 58 57.83(11.90) .339 10.57(9.16) .077 25.11(20.71) .134 
 No 47 55.45(13.48) 8.17(9.89) 18.85(19.55) 
Egg Yes 56 57.57(12.27) .485 10.02(8.68) .229 22.22(20.44) .913 
 No 49 55.84(13.09) 8.90(10.46) 22.36(20.44) 
Peanut Yes 67 58.13(11.73) .140 9.01(8.87) .614 22.24(21.15) .870 
 No 38 54.34(13.90) 10.37(10.65) 22.35(19.34) 
Tree Nut Yes 51 58.50(11.87) .171 10.41(9.36) .314 29.23(21.75) .002** 
 No 54 55.12(13.12) 8.64(9.68) 15.85(16.72) 
Soy Yes 24 57.17(12.86) .859 9.06(7.36) .625 20.70(16.64) .997 
 No 81 56.64(12.63) 9.63(10.11) 22.73(21.35) 
Wheat Yes 20 58.60(10.34) .472 9.15(10.19) .863 26.80(22.12) .337 
 No 85 56.33(13.12) 9.58(9.42) 21.21(19.88) 
Fish Yes 5 61.60(5.13) .383 12.00(11.05) .606 27.20(24.39) .746 
 No 100 56.52(12.85) 9.37(9.49) 22.03(20.23) 
Shellfish Yes 7 61.14(4.85) .057 10.57(8.22) .560 28.00(22.06) .572 
 No 98 56.45(12.96) 9.42(9.64) 21.93(20.30) 
Sesame Yes 23 57.13(13.93) .884 8.26(8.03) .626 24.23(21.21) .673 
 No 82 56.66(12.33) 9.85(9.92) 21.67(20.18) 
 Accident and Emergency attended at least once due to food allergy; Anaphylaxis Symptoms = Parent reports having at least one child who has 
experienced at least three symptoms indicative of anaphylaxis during allergic reactions; Mild-Moderate Symptoms = Parent reports having at 
least one child who has experienced at least six mild-moderate symptoms during allergic reactions; Gastrointestinal Symptoms = Parent reports 
having at least one child who has experienced at least three gastrointestinal symptoms during allergic reactions. 
aindependent samples t-test  bMann-Whitney U test 
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For worry, the regression analysis presented in the empirical paper included 
the only variables with a significant correlation with or difference in scores on the 
PSWQ (Meyer, Miller, Metzger, & Borkovec, 1990). Therefore no further regression 
analysis was conducted. 
For anxiety, a binary logistic regression was conducted with anaphylaxis 
symptoms, gastrointestinal symptoms, parent food allergy, parent currently taking 
mood medication, and wait time for diagnosis included in the first step, and 
intolerance of uncertainty and food allergy self-efficacy added in the second step 
(Table 15). This model led to a significant improvement in the classification of 
clinical cases, χ2(7) = 29.20, p<.001, and was found to be a good fit to the data, 
Hosmer-Lemeshow χ2(8) = 6.068, p=.640. Within this model, only gastrointestinal 
symptoms remained individually significantly predictive. The model correctly 
classified 76.2% of participants (Table 16), with improvements in both sensitivity 
and specificity compared to the regression model presented in the empirical paper.  
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Table 15 
Exploratory Logistic Regression Model for Anxiety in Parents of Children with Food 
Allergies 
 
Predictor β SE β p OR (eβ) [95% 
confidence intervals] 
Step 1     
Anaphylaxis 
Symptoms 
-0.49 .48 .300 0.61[0.24, 1.55] 
Gastrointestinal 
Symptoms 
-1.59 .49 .001** 0.20[0.08, 0.53] 
Time for 
diagnosis 
-0.01 .02 .331 0.99[0.96, 1.02] 
Parent Food 
Allergy 
1.40 .88 .112 4.05[0.72, 22.75] 
Parent Mood 
Medication 
-1.88 .88 .032* 0.15[0.03, 0.86] 
Constant 1.15 1.25 .357 3.15 
Step 2     
Anaphylaxis 
Symptoms 
-0.54 .50 .274 0.58[0.22, 1.54] 
Gastrointestinal 
Symptoms 
-1.68 .51 .001** 0.19[0.07, 0.51] 
Time for 
diagnosis 
-0.02 .02 .250 0.98[0.96, 1.01] 
Parent Food 
Allergy 
1.37 .91 .130 3.94[0.67, 23.26] 
Parent Mood 
Medication 
-1.79 .91 .050 0.17[0.03, 1.00] 
IUS-S 0.05 .03 .064 1.05[1.00, 1.10] 
FASE-P -0.01 .02 .487 0.99[0.95, 1.02] 
Constant 0.47 2.31 .838 1.60 
Note. Anaphylaxis Symptoms = Parent reports having at least one child who has 
experienced at least three symptoms indicative of anaphylaxis during allergic 
reactions; Gastrointestinal Symptoms = Parent reports having at least one child who 
has experienced at least three gastrointestinal symptoms during allergic reactions; 
IUS-S = Intolerance of Uncertainty Scale – Short Form; FASE-P = Food Allergy 
Self-Efficacy Scale for Parents. 
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Table 16 
Classification Table for Exploratory Logistic Regression Model of Anxiety 
 
Observed Predicted Percentage Correct 
 No-Mild 
Anxiety 
Moderate-
Severe Anxiety 
 
No-Mild Anxiety 54 8 87.1 
Moderate-Severe Anxiety 16 23 59.0 
 
Overall Correct 
   
76.2 
 
For PTSS, a binary logistic regression was completed with an AAI having 
been administered, gastrointestinal symptoms, having a child with tree nut allergy, 
and parent food allergy included in step 1, and intolerance of uncertainty and food 
allergy self-efficacy added in step 2 (Table 17). This model led to a significant 
improvement in the classification of clinical cases, χ2(6) = 43.43, p<.001, and was 
found to be a good fit of the data, Hosmer-Lemeshow χ2(8) = 5.60, p=.692. Within 
this model, an AAI having been administered, gastrointestinal symptoms, and 
intolerance of uncertainty remained significantly predictive. The model correctly 
classified 75.0% of participants (Table 18), which is a slight reduction in overall 
correct classifications and specificity but an improvement in sensitivity compared to 
the main regression model.  
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Table 17 
Exploratory Logistic Regression Model of Parental PTSS in Food Allergies 
 
Predictor β SE β p OR (eβ) [95% 
confidence intervals] 
Step 1     
AAI given -1.76 .63 .005** 0.17[0.05, 0.59] 
Gastrointestinal 
Symptoms 
-1.14 .49 .019* 0.32[0.12, 0.83] 
Tree Nut Allergy -0.81 .48 .092 0.45[0.18, 1.14] 
Parent Food 
Allergy 
1.68 1.14 .138 5.39[0.58, 49.96] 
Constant 0.52 1.28 .683 1.69 
Step 2     
AAI given -1.92 .68 .005** 0.15[0.04, 0.56] 
Gastrointestinal 
Symptoms 
-1.20 .54 .027* 0.30[0.10, 0.87] 
Tree Nut Allergy -0.90 .54 .093 0.41[0.14, 1.16] 
Parent Food 
Allergy 
1.58 1.21 .190 4.87[0.46, 51.75] 
IUS-S 0.06 .03 .018* 1.07[1.01, 1.13] 
FASE-P -0.04 .02 .068 0.97[0.93, 1.00] 
Constant 1.04 2.26 .646 2.83 
Note. AAI Given = Adrenaline auto-injector administered at least once during an 
allergic reaction; Gastrointestinal Symptoms = Parent reports having at least one 
child who has experienced at least three gastrointestinal symptoms during allergic 
reactions; IUS-S = Intolerance of Uncertainty Scale – Short Form; FASE-P = Food 
Allergy Self-Efficacy Scale for Parents.  
 
Table 18 
Classification Table for Exploratory Logistic Regression Model of PTSS 
 
Observed Predicted Percentage Correct 
 IES-R below 24 IES-R above 24  
 
IES-R below 24 
 
46 
 
14 
 
76.7 
 
IES-R above 24 
 
12 
 
32 
 
72.7 
 
Overall Correct 
 
 
  
75.0 
Note. IES-R = Impact of Events Scale – Revised.  	
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Overall, these exploratory analyses highlight some additional variables that 
could warrant consideration in future research. In particular, gastrointestinal 
symptoms, which remained significant in both anxiety and PTSS regression models. 
However, as an exploratory exercise, it is not appropriate to draw conclusions from 
this data. 
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Chapter 6: Discussion 
 
This portfolio presented a systematic review with meta-analysis that aimed to 
estimate the prevalence of anxiety, depression, and post-traumatic stress symptoms 
(PTSS) in children with food allergy, and compare this to children without food 
allergy. An original piece of empirical research was subsequently presented to assess 
whether parents of children with food allergy report clinically significant anxiety, 
worry and PTSS, and whether these psychological outcomes could be predicted by 
allergy severity, intolerance of uncertainty, and food allergy self-efficacy. Finally, an 
exploratory analysis was conducted with the aim of identifying additional food 
allergy or demographic variables that could warrant further exploration in future 
research assessing psychological wellbeing in parents of children with food allergy. 
This chapter offers a summary of results, before discussing the theoretical and 
clinical implications of the portfolio, offering a critical evaluation of the work, and 
ending with suggestions for future research in the field. 
 
Summary of Results 
The systematic review highlighted the heterogeneity in the current evidence base for 
anxiety, depression and PTSS in children with food allergy. Whilst this limits the 
robustness of the results of the review, there are indications of a small but significant 
increase in anxiety (d= 0.21, 95% CIs 0.16-0.26) and depression (d=0.30, 95% CIs 
0.14-0.45) in children with food allergy compared to their peers without food allergy. 
However, these results were not consistent across anxiety disorders, with evidence of 
increased separation anxiety and generalized anxiety, but no significant difference in 
social anxiety. Only one paper was identified assessing PTSS in a child food allergy 
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population (Weiss & Marsac, 2016); as a pilot study this study had a small sample 
size, and was also conducted immediately following a food challenge; as such, it was 
not possible to draw any conclusions on the prevalence or difference in PTSS within 
this population. 
 The empirical paper found high rates of worry (81.0%), anxiety (39.1%) and 
food allergy related PTSS (42.3%) in parents of children with food allergy. Increased 
intolerance of uncertainty was significantly positively correlated with all three 
psychological outcomes, and increased food allergy self-efficacy was significantly 
negatively correlated with all three outcomes, as expected. Mixed results were found 
for allergy severity variables, with higher scores on all three psychological outcome 
measures observed in parents that reported their children to have experienced more 
anaphylaxis symptoms. For worry and PTSS significantly higher scores were also 
found in parents that reported an adrenaline auto-injector (AAI) to have been 
administered during an allergic reaction, and PTSS was also significantly higher in 
parents whose children had attended A&E due to an allergic reaction. However, no 
significant differences were observed for an AAI being prescribed or for parents that 
reported their children to have previously experienced an anaphylactic reaction.  
 Regression analyses were conducted including an AAI having been 
administered for worry (multiple linear regression) and PTSS (logistic regression), 
and parent reported anaphylaxis symptoms for anxiety (logistic regression), in 
addition to intolerance of uncertainty and food allergy self-efficacy for all 
psychological outcomes. In these analyses, intolerance of uncertainty was the only 
variable to consistently remain individually significantly predictive within the 
models. For worry and PTSS, an AAI having been administered was also 
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significantly predictive. However, food allergy self-efficacy did not remain a 
significant predictor in any of the three regression analyses. 
 The exploratory analysis presented in Chapter 5 offered additional significant 
variables that may warrant further exploration in relation to anxiety and PTSS, but 
not worry. For anxiety this included parent reported child gastrointestinal symptoms 
during allergic reaction (higher anxiety), parents having a food allergy themselves 
(lower anxiety), longer waiting time to receive food allergy diagnosis (higher 
anxiety), and parents currently taking medication for their mood (higher anxiety). 
For PTSS the additional significant variables were parent reported child 
gastrointestinal symptoms (higher PTSS), child tree nut allergy (higher PTSS), and 
parents having a food allergy themselves (lower PTSS). Exploratory logistic 
regression analyses including these variables in addition to those included in the 
empirical paper, for anxiety found gastrointestinal symptoms to be the only variable 
to remain individually significantly predictive, whilst for PTSS gastrointestinal 
symptoms, an AAI having been administered, and intolerance of uncertainty all 
remained individually significantly predictive. 
  
Links to Previous Research 
Anxiety 
Although conclusions on prevalence and difference compared to non-food allergy 
populations cannot be drawn (due to the extent of heterogeneity in the meta-analysis, 
and self-selecting sample and lack of comparison group in the empirical paper), the 
papers within this portfolio do provide an indication of elevated levels of anxiety in 
children with food allergy and their parents.  
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In children, the overall estimated anxiety prevalence rate of 12.6% was 
higher than general population estimates of 6.5% (Polanczyk, Salum, Sugaya, Caye, 
& Rohde, 2015). However, particular caution is needed with interpreting this 
difference as Polanczyk et al. were able to use far more stringent inclusion criteria, 
and a high degree of heterogeneity was observed in the portfolio’s meta-analysis. 
The estimated pooled effect size for difference between children with and without 
food allergy (d=0.21) was comparable to the pooled effect size found in a meta-
analysis of anxiety in children with and without any chronic health condition 
(d=0.18; Pinquart & Shen, 2011), although in both instances a high degree of 
heterogeneity was observed.  
Within anxiety disorder specific syntheses, there was a mixed pattern of 
results for children with food allergy. Interestingly, these results appear to mirror 
suggestions in previous literature assessing factors that may impact on the mental 
health of children with food allergy, as well as the medical management of allergy. 
For example that children with food allergy may find it harder to be away from home 
and parents (e.g. Sanagavarapu, 2012), or that a degree of anxiety may be needed for 
children to be sufficiently vigilant in their allergy management (Mandell, Curtis, 
Gold, & Hardie, 2005). 
In parents, the most notable results were for worry, with 81.0% of 
participants scoring above the Penn State Worry Questionnaire’s (PSWQ; Meyer et 
al., 1990) clinical cut-off for worry as a transdiagnostic mental health symptom 
(Behar, Alcaine, Zuellig, & Borkovec, 2003), and 35.2% scoring above the higher 
threshold previously found to have good discriminative validity for generalized 
anxiety disorder (GAD; Chelminski & Zimmerman, 2003). These results are in 
keeping with previous qualitative research that has suggested increased worry in 
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parents of children with food allergy (e.g. Akeson et al., 2007; Sanagavarapu, 
Wainstein, Children, & Katelaris, 2016).  The rate of clinically significant worry 
found in the empirical paper sample is also substantially higher than general 
population estimates for GAD, with 12-month prevalence estimates of 1.3-3.1% for 
those meeting full diagnostic criteria (Wittchen, 2002), and 2.1%-7.7% when sub 
diagnostic GAD is included (Haller, Cramer, Lauche, Gass, & Dobos, 2014). 
However, these prevalence estimates have not used the PSWQ. The mean score 
found on the PSWQ in the empirical paper (56.77) is also substantially higher than 
general population norms (mean = 42.2; Gillis, Haaga, & Ford, 1995), with both the 
mean and median (59) score found in the empirical paper falling in the 80th-90th 
percentile of general population scores for the 18-44 years age range (the most 
closely comparable to the present study population).  
 Whilst worry was relatively pervasive in the empirical paper sample, anxiety 
was also elevated compared to general population norms. The mean score on the 
Depression Anxiety Stress Scales 21 (DASS-21) Anxiety subscale (Lovibond & 
Lovibond, 1995) in the empirical paper was 9.42, whereas in a large British general 
population sample a mean score of 3.76 has been found (Henry & Crawford, 2005). 
The median score in the present study population was also notably higher than the 
median general population score, eight and two respectively. This indicates a pattern 
of more general increased anxiety, rather than a small number of particularly anxious 
parents increasing the mean scores within the study. Using the more detailed 
normative data available for the full DASS (which has good convergent validity and 
comparable scoring to the DASS-21; Henry & Crawford, 2005), similarly to the 
results for worry, the median anxiety score found in the empirical paper was within 
the 80th-90th percentile of general population norms (Crawford & Henry, 2003). 
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Whilst the DASS-21 is not designed as a diagnostic tool, the items within the anxiety 
subscale are typical of panic type anxiety, which was the rationale for the additional 
inclusion of this measure alongside the PSWQ.  
Overall, while a greater proportion of participants in the empirical paper 
scored in the clinical range for worry, comparison to previously published norms 
indicate that parents in the study were reporting notably elevated levels of both 
worry and panic type anxiety symptoms, with median scores falling in the 80th-90th 
percentile range.  Therefore, while conclusions on prevalence cannot be drawn, it 
seems unlikely that these results could be explained exclusively by the use of a self-
selected sample in the empirical research project. 
 
Post-Traumatic Stress 
 As only one pilot study was found assessing PTSS in children, no meaningful 
comparisons or conclusions can be drawn from this data. However, the empirical 
study was the first study to assess PTSS in parents of children with food allergy, and 
with a relatively large sample size, it is useful to consider these results in relation to 
previous literature.  
 Firstly, the presence of PTSS found in the empirical paper is congruent with 
qualitative research exploring parents’ experience of caring for a child with food 
allergy (Abdurrahman et al., 2013; Rouf, White, & Evans, 2012). For example, Rouf 
et al. includes quotes of parents describing what sounds like re-experiencing 
symptoms. The results of the empirical study support these previous suggestions, and 
highlight the need for further research assessing PTSS in this population. 
 In the wider paediatric literature, Price et al.'s  (2016) review of paediatric 
medical traumatic stress research reported a rough prevalence estimate of PTSS as 
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30% across potentially traumatic medical events and conditions, with a trend in 
declining symptoms over time. However, they observed a high degree of 
heterogeneity in estimates. The largest numbers of PTSS studies were found for 
paediatric injury and cancer, with generally higher rates of PTSS observed in the 
cancer literature. The rates of clinically significant PTSS observed in the empirical 
study (42.3%) were comparable to the lower end of the prevalence estimates 
observed in parents in the first month following cancer diagnosis (40-83%; Price et 
al., 2016), with prevalence of PTSS in the cancer literature at 10 months having 
dropped to 7-20%. Within the empirical paper, time since the stressful event was 
reported but not controlled for, and PTSS symptoms were assessed over the past 
week, as such resolved PTSS was not accounted for. However, amongst those 
reporting clinically significant PTSS the median time since the stressful event was 11 
months. Given this, the rates of PTSS observed in the empirical study are 
surprisingly high.  
 Whilst the results of the empirical study need to be interpreted with caution 
given the cross-sectional design and self-selecting sample, the PTSS measure was 
completed specifically in relation to a food allergy related event, and given this has 
not previously been researched the presence of PTSS in this population is an 
important and valuable finding.  
 
Depression 
 Depression was not assessed in parents with food allergy. However, the meta-
analysis indicated increased rates of depression in children with food allergy. For 
prevalence, the meta-analysis generated a pooled prevalence of 6.9%, compared to 
general child prevalence estimates of 2.9% (Polanczyk et al., 2015), although the 
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same caution is required as in the anxiety comparison due to heterogeneity and 
differences in inclusion criteria. The pooled effect size for difference calculated in 
the portfolio’s meta-analysis (d=0.30) was higher than that found in a meta-analysis 
of children with any chronic health condition compared to healthy child populations 
(d=0.19; Pinquart, Shen, & Sych, 2011). Whilst a particularly high degree of 
heterogeneity was observed in the depression synthesis, limiting the robustness of 
this finding, it is nevertheless an interesting result that warrants further exploration.  
 
Predictors of Psychological Outcomes 
 Within the empirical paper, intolerance of uncertainty being a consistently 
strong predictor of mental health outcomes is consistent with the wider literature. 
While intolerance of uncertainty is widely considered in relation to generalized 
anxiety disorder (e.g. Dugas, Gagnon, Ladouceur, & Freeston, 1998; Buhr & Dugas, 
2006), more recently, research has suggested that intolerance of uncertainty may be a 
transdiagnostic maintaining factor across both anxiety disorders and depression (e.g. 
Carleton et al., 2012; Mahoney & McEvoy, 2012). It is congruent with this literature 
that whilst the largest effect size was found for worry, intolerance of uncertainty also 
showed medium-large correlations with anxiety and PTSS. 
  More surprisingly, parents’ food allergy related self-efficacy was not a 
strong predictor of psychological outcomes. Self-efficacy (Bandura, 1988; Cramm, 
Strating, Roebroeck, & Nieboer, 2013), and particularly domain specific self-
efficacy (e.g. Rezendes & Scarpa, 2011; Streisand et al., 2008) have been widely 
suggested to be protective factors for anxiety and psychological wellbeing. Self-
efficacy is one component of an individual’s perceived capacity to cope in the 
secondary reappraisal phase of Clark and Beck’s (2010) model of anxiety. Within 
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food allergy it has also been suggested that confidence in allergy management may 
help to explain inconsistent findings between allergy severity and psychological 
outcomes (Cummings, Knibb, King, & Lucas, 2010). While significant correlations 
between food allergy self-efficacy and worry, anxiety, and PTSS were found, the 
effect size was generally small, and self-efficacy did not remain significant in any of 
the regression models. As there was a reasonable spread of scores on the measure 
used to assess food allergy self-efficacy in the empirical research project (Food 
Allergy Self-Efficacy Scale for Parents, FASE-P; Knibb, Barnes, & Stalker, 2015), 
with no indications of a ceiling effect, these results cannot be readily explained 
through potential measurement issues. As such, it is useful to consider possible 
reasons a true small effect size may be found for self-efficacy.  
Firstly, the FASE-P (Knibb et al., 2015) assesses parents’ own confidence in 
allergy management. While the FASE-P does include items relating to having 
confidence in making plans with others to ensure their child’s safety, it does not 
explicitly consider their confidence in their child’s own allergy management, or 
confidence in the ability of other adults with caring responsibility (e.g. teachers) to 
recognize and respond to allergic reactions. As the potential threat is to the child and 
not directly to the parent themselves, it is possible that parents’ confidence in other 
individuals to whom they need to delegate responsibility would be equally important 
as their own confidence in terms of the psychological impact of food allergy (e.g. 
Sanagavarapu et al., 2016). However, there is currently no standardized way to 
assess this.  
Additionally, confidence in the practical management of food allergy is only one 
facet to an individual’s overall perception of their capacity to cope, other variables 
such as perceived emotional resilience of themselves and their child, could also be 
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considered in the secondary appraisal phase of Clark and Beck’s (2010) 
transdiagnostic model of anxiety. The relatively small effects found for food allergy 
self-efficacy cannot infer that these additional factors would not be important. 
 As per previous food allergy literature (e.g. Cummings, Knibb, Erlewyn-
Lajeunesse et al., 2010; Marklund et al., 2006), mixed findings were found for the 
relationship between allergy factors and psychological outcomes. While any attempts 
to explain these differences are tentative, some of the main results for allergy factors 
are broadly in keeping with suggestions from previous literature. For example, 
parents of children with Type I diabetes have reported giving injections and 
emergency hospital attendance as the two most distressing diabetes related events 
(Horsch, Mcmanus, & Edge, 2007). These factors may help to explain why an AAI 
having been given was a significant predictor of worry and PTSS, whereas having an 
AAI prescribed was not. However, this cannot explain why an AAI being 
administered was not a significant predictor of anxiety symptoms or why A&E 
attendance was only significantly related to PTSS.  
Within the exploratory analysis, the finding that gastrointestinal symptoms were 
a good predictor of anxiety and PTSS is broadly in keeping with the results of 
Marklund et al. (2006), and the suggestion that these symptoms may be more 
distressing due to the lack of available treatment (Cummings, Knibb, King, & Lucas, 
2010). However, Marklund et al.’s (2006) study used a quality of life measure with a 
general item regarding the worry or concern that child health causes parents. While 
parents experiencing food allergy related PTSS might reasonably be expected to 
score more highly on this type of question, it is less congruent that the empirical 
project found differences on the anxiety but not worry questionnaire for parents of 
children with more gastrointestinal symptoms.  
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Overall, while there are some suggestions for the direct impact particular allergy 
symptoms or events could have on psychological wellbeing, these are not 
consistently supported in the empirical project or wider literature. As such, while 
they may warrant further consideration in future research, no firm conclusions can 
currently be drawn on the predictive power of allergy factors for mental health. 
 
Theoretical Implications 
Presence of Mental Health Difficulties in Children with Food Allergy and their 
Parents 
While neither the meta-analysis nor the empirical paper can draw firm 
conclusions on the prevalence of mental health difficulties in children with food 
allergy or their parents, the indication of increased anxiety that they provide lends 
support to suggestions that this population may be at increased risk of anxiety due to 
factors such as the need to tolerate the risk of accidental exposure and/or the 
potentially distressing nature of allergic reactions (e.g. Abdurrahman et al., 2013; 
Lau et al., 2014; Sanagavarapu, 2009; Sanagavarapu et al., 2016). 
 Within the anxiety results, a consistent finding across the meta-analysis and 
empirical paper was higher rates of worry. Previous research has theorised that 
increased worry may be an adaptive response in food allergy (e.g. Avery, King, 
Knight, & Hourihane, 2003; Mandell et al., 2005) as it could help with being more 
vigilant in the avoidance of allergens, in turn improving allergy management. 
However, when considering the items included in the PSWQ (Meyer et al., 1990; 
Appendix L), the measure used in the empirical research project, there is an 
emphasis on worry being pervasive and overwhelming, which is similar in 
alternative measures of clinically significant worry. As such, it seems reasonable to 
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suggest that scoring highly on these measures would indicate an extent of worry that 
goes beyond an adaptive response to a health condition, and would be expected to 
have a negative impact on an individual’s psychological wellbeing. Theoretically, 
this highlights a need to distinguish normative adaptive responses, from a longer-
term negative psychological impact. To help achieve this, it would be useful for 
future research to focus on refining assessments of food allergy specific anxiety (e.g. 
FAQLQ-PF food anxiety subscale; DunnGalvin, de BlokFlokstra, Burks, Dubois, & 
Hourihane, 2008), in particular working towards developing a clinical cut-off for 
these measures. As an anxiety measure specific to food allergy is likely to have 
better discriminative power for assessing more and less helpful forms of worry. 
 The portfolio also indicates that it is possible for both parents (empirical 
paper) and children (Weiss & Marsac, 2016) to experience significant PTSS in 
response to food allergy related events. Whilst this is not theoretically surprising, 
given allergic reactions can cause physical harm and at their most severe risk to life, 
and the presence of literature showing PTSS in similar health conditions (e.g. 
asthma; Kean et al., 2006), this was the first study to confirm this in parents of 
children with food allergy using a validated trauma measure. Furthermore, in line 
with Price et al.'s (2016) model of pediatric medical traumatic stress, within the 
empirical paper significant PTSS was in some cases reported in response to less 
severe allergic reactions or food allergy related events. This supports the suggestion 
that within paediatric literature it is important to consider PTSS more broadly than 
those who would meet the full criteria for PTSD (Kazak et al., 2006). 
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Possible Mechanisms Between Food Allergy and Anxiety and PTSS 
Although the aim of the portfolio was not to generate theory, or a model of the 
psychological impact of food allergy, the empirical paper did aim to contribute to an 
understanding of possible risk factors of anxiety and PTSS in this population, and as 
such can offer some theoretical suggestions. 
 Individual Factors. Individual factors that increase an individual’s 
perception of threat and/or risk are widely theorised to increase anxiety. This is 
included in Clark and Beck’s (2010) transdiagnostic model of anxiety, Price’s model 
of pediatric medical traumatic stress (Price et al., 2016), and Dugas’s model of GAD 
(Dugas et al., 1998). The empirical paper supports this suggestion, as intolerance of 
uncertainty was found to be a good predictor of all three psychological outcomes, 
and was the most consistent predictor included in the study.  
Intolerance of uncertainty is thought to stem from an individual’s negative 
beliefs relating to the implications of uncertainty, resulting in finding uncertain 
situations stressful and/or upsetting (Buhr & Dugas, 2009). This can lead individuals 
to unhelpful attempts to control or avoid uncertainty (Buhr & Dugas, 2009). As 
discussed throughout this portfolio, avoidance of food allergens is reliant on a 
number of factors that cannot be readily controlled for (e.g. human error in food 
preparation). Therefore, parents of children with food allergy are required to either 
manage a relatively high degree of uncertainty surrounding allergen exposure (likely 
to be highly anxiety provoking for those who hold negative beliefs around 
uncertainty), or alternatively take relatively drastic measures to control for accidental 
exposure, likely to have a profound impact on quality of life. As such, it makes 
theoretical sense that within food allergy a disposition for intolerance of uncertainty 
could be particularly challenging. 
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The strong relationship between an individual’s threat perception and 
psychological outcomes may also provide an alternative theoretical reason for the 
relatively small effect sizes observed for self-efficacy. As if parents have an 
especially high sense of threat, particularly one that exceeds the objective medical 
threat posed by allergy (e.g. Ogg, Wong, Wan, Davis, & Arkwright, 2017), it may 
not be feasible for parents’ confidence to moderate this sufficiently to be a strong 
protective factor. 
Allergy Factors. Similarly to the wider food allergy literature, mixed results 
were found for the relationship between allergy factors and psychological outcomes. 
Whilst the possibility of spurious findings cannot be ruled out, it is possible that 
these mixed findings could be theoretically explained. It was not the aim of the 
present research to explore these theoretical pathways, but initial tentative 
hypotheses are offered below. 
While, as previously discussed, it is possible that particular allergy symptoms or 
events are inherently more distressing, the mixed results may be due to indirect 
pathways between allergy factors and psychological outcomes. It may be that 
particular allergy variables are associated with higher presence of different individual 
or environmental risk factors, which in turn are predictive of poorer psychological 
outcomes. For example, one potential hypothesis could be that parents of children 
with milder allergies (e.g. as represented by primarily gastrointestinal symptoms) 
may receive less understanding or caution from others, which in turn could increase 
parents’ perception of social threat and perceived likelihood of allergic reaction. 
Furthermore, parents of children with milder symptoms may need to tolerate more 
uncertainty surrounding reactions, due to delayed allergic reactions (NICE, 2011a), 
and more ambiguity of allergic symptoms (i.e. there are many possible causes of 
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gastrointestinal and skin symptoms). In contrast, for children at greater risk of 
anaphylaxis, the greatest threat may be physical, for example an increased perceived 
risk of the likelihood of death from an allergic reaction (Ogg et al., 2017). Given in 
the wider anxiety literature one of the key distinguishing factors between disorder 
specific models is the content of threat related cognitions (Clark & Beck, 2010), 
these types of differences may help to explain the different pattern of results 
observed for allergy factors between psychological outcomes and studies. 
The exploratory analysis raised an additional interesting allergy related result, in 
the potential protective impact of parents having a food allergy themselves. This was 
observed for both anxiety and PTSS. Particular caution is needed in interpreting this 
result as no adjustments were made for multiple testing within the exploratory 
analysis, and only 10 participants (9.5%) had a food allergy themselves, limiting the 
power and generalisability of these analyses. However, it could be beneficial for 
future research to explore this further both quantitatively and qualitatively to 
understand whether there is something about parents’ own experience of food allergy 
which is protective for psychological responses to their child’s allergy. As if this 
finding is supported, a better understanding of how parents’ own experience has a 
protective effect could help facilitate the development of interventions for parents 
who are experiencing difficulties with the psychological impact of food allergy. 
Relationship between parent and child mental health. Although the portfolio 
did not aim to directly compare the psychological outcomes for parents and children, 
the results of the two papers in combination with the wider anxiety literature raise an 
additional possible theoretical pathway for child psychological outcomes. As 
highlighted in the bridging chapter, the patterns of elevated mental health problems 
(increased separation anxiety, generalized anxiety, and depression, but no increased 
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social anxiety) found in the meta-analysis in the present portfolio, mirror the results 
found in Lawrence et al.'s (2019) meta-analysis exploring the impact of parent 
anxiety disorders on child anxiety. Interestingly, whilst Lawrence et al.'s meta-
analysis did not find evidence of increased risk of children experiencing the same 
anxiety disorder as their parents, they generally found the largest effect sizes for 
children of parents who met diagnostic criteria for GAD. Given the high rates of 
clinically significant worry found in the empirical paper, with 35.2% also reaching a 
cut-off found to have discriminative validity for GAD (Chelminski & Zimmerman, 
2003), it is possible that the elevated mental health difficulties observed in children 
with food allergy, may at least in part be an indirect influence of the psychological 
impact food allergy has for their parents.  
This is particularly notable, as the only study within the systematic review 
presented in this portfolio that did not find a significant difference in GAD between 
children with and without food allergy was King, Knibb, and Hourihane (2009) 
whose comparison group comprised of older siblings without food allergy. This was 
the only study using this design, and in this instance parental factors would be 
shared. While a medium effect was still found in separation anxiety in King et al.’s 
study, as the children without food allergy were required to be older siblings, 
increased separation anxiety in the food allergy group could be expected irrespective 
of health status (Spence, Zubrick, & Lawrence, 2018). Whilst at this stage this is a 
very tentative hypothesis, this potential pathway does warrant further exploration as, 
if it were supported, it would have important clinical implications for successful 
management of the psychological impact of food allergy. 
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Clinical Implications 
 Clinically, one of the most notable implications of the portfolio is the need 
for greater awareness of the potential impact of food allergy on both child and 
parent’s mental health. For those working in allergy settings, in the short term it 
would be useful for clinicians to have awareness of the anxiety that children and 
parents can experience, and that some individuals experience PTSS in relation to 
food allergy related events. It could be beneficial for allergy clinicians to ask about 
psychological wellbeing at allergy appointments, and consider making a referral to 
local psychological services if either parents or children are experiencing difficulties, 
and no specialist psychological provision is available. This is particularly notable as 
the results of the empirical paper suggest working to improve confidence in allergy 
management is unlikely to be sufficient for improving mental health.  
In the longer term, it may be beneficial to more formally include a brief 
screen for psychological wellbeing in children and parents during allergy diagnosis 
or review, with an established onwards pathway to psychological support, such as is 
currently recommended in paediatric diabetes (NICE, 2016). However, the feasibility 
of this form of widespread programme is likely dependent on further research 
assessing the more direct impact of food allergy on psychological wellbeing, such as 
assessing PTSS longitudinally after diagnosis/allergic reactions, and further research 
evaluating food allergy specific anxiety.  
 For psychologists and other mental health professionals, the portfolio 
highlights some factors that may be useful to consider in the assessment and 
treatment of mental health in parents of children with food allergy. Firstly, although 
mixed results were found for the relationship between allergy factors and 
psychological outcomes, the results of the PTSS measure in the empirical paper 
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identify that some parents do find specific allergy related events highly distressing. 
The regression analyses also suggest certain factors such as an AAI having been 
administered may be significantly predictive of worry and PTSS. These allergy 
related events therefore warrant consideration in the assessment and formulation of 
psychological distress in food allergy. The strong relationship found between 
intolerance of uncertainty and psychological outcomes also indicates that this may be 
a promising target for intervention in this population, and warrants consideration in 
the formulation of psychological distress. 
 Within the GAD literature, cognitive behavioural therapy (CBT) treatment 
programmes directly focused on intolerance of uncertainty have been developed 
(Dugas & Ladouceur, 2000). These interventions typically involve distinguishing 
worries that can and cannot be problem solved, increasing tolerance of unsolvable 
worries (through exposure), and developing positive beliefs about worry (van der 
Heiden, Muris, & van der Molen, 2012). However, within the empirical paper 
intolerance of uncertainty was found to be a good predictor across psychological 
outcomes, and this intervention may not be appropriate where worry is not the 
primary presenting problem. 
In more recent years, intolerance of uncertainty has been considered 
transdiagnostically as well as in relation to GAD (e.g. (Mahoney & McEvoy, 2012). 
This has led to the consideration of intolerance of uncertainty in transdiagnostic 
CBT. A randomized control trial of transdiagnostic CBT for anxiety (Boswell, 
Thompson-Hollands, Farchione, & Barlow, 2013), found decreases in intolerance of 
uncertainty, which in turn was associated with improved mental health outcomes at 
the end of treatment. This trial used the Unified Protocol for the Transdiagnostic 
Treatment of Emotional Disorders (Barlow et al., 2011), which does not explicitly 
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address intolerance of uncertainty, but focuses more broadly on common features 
across anxiety disorders and depression. The results of this trial therefore suggest 
that CBT may be an effective approach for targeting intolerance of uncertainty, 
including where intolerance of uncertainty is not the sole focus of the intervention, 
and where worry is not the primary presenting problem.  These are promising 
findings for the potential psychological treatment for parents of children with food 
allergy. 
 Two previous studies have also reported on CBT-based interventions with 
mothers of children with food allergy. Firstly, Boyle et al. (2017) assessed a brief 
CBT-based intervention (single session with two follow-ups) designed to primarily 
target mothers’ perception of risk of anaphylaxis, compared to a standard care 
control group. Although maternal state anxiety did not significantly improve 
following the intervention, there was a significant improvement in those who 
completed the interventions perception of risk of anaphylaxis and fatal reactions, and 
improved stress response to a simulated anaphylaxis reaction maintained at a 1-year 
follow-up. Given the brevity and specificity of the intervention, these generally 
appear to be positive results. However, the lack of significant difference for maternal 
anxiety may highlight the need to consider broader factors (e.g. intolerance of 
uncertainty) as well as allergy specific risks in psychological treatment, going 
beyond a brief intervention. 
A case series of CBT for mothers with food allergy (Knibb, 2015), whereby 
12 sessions of target statement driven CBT was offered to five mothers of children 
with food allergy, found significant reductions in anxiety, worry, and depression at 
the end of treatment. While this is a very small sample size, it suggests that CBT may 
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be an effective intervention for psychological distress in mothers of children with 
food allergy.  
Overall, the results of the empirical study in combination with previous 
anxiety and food allergy literature indicate that CBT may be a promising approach 
for treating the psychological impact of food allergy, and intolerance of uncertainty 
may warrant particular attention in therapy. 
 
Strengths and Limitations 
A notable strength of the thesis portfolio is the consideration of PTSS in both the 
systematic review and empirical paper. The need for this research has been 
repeatedly highlighted (e.g. Kelsay, 2003; Akeson et al., 2007), but as further evident 
in the systematic review has remained largely unaddressed. The empirical research 
project, and the one pilot study found assessing PTSS within the systematic review 
(Weiss & Marsac, 2016), indicate that both parents and children can experience 
significant trauma symptoms in relation to food allergy related events. With these 
initial results, further research in this area is clearly warranted to add more depth to 
these initial findings.  
A further strength was the consideration of different forms of anxiety. While in 
the wider anxiety literature, it is mostly accepted that it is valuable to consider 
anxiety in a disorder specific as well as in a transdiagnostic or unitary way (e.g. 
McManus, Shafran, & Cooper, 2010), within physical health psychology literature 
anxiety, particularly parental anxiety, is often measured as a unitary construct (e.g. 
Cortes, Castillo, & Sciaraffia, 2018; Lau et al., 2014). Considering different types of 
anxiety is useful in providing more detailed understanding of the psychological 
impact health conditions can have for both parents and children, as well as leading to 
121 
recommendations for interventions. This is evident in the different rates of forms of 
anxiety observed in both the meta-analysis and empirical paper, as well as 
differences in the patterns of some predictors across psychological outcomes in the 
empirical paper. 
 Whilst a strength of the portfolio is considering both child and parent 
wellbeing, the portfolio is limited by considering this separately. While the review 
and research questions did not require both parent and child mental health to be 
assessed within the individual chapters, doing so might have improved the 
explanatory power of the results. This is particularly notable given the patterns of 
mental health in children appeared to mirror the results of Lawrence et al.'s (2019) 
meta-analysis reviewing the impact of parent anxiety for child mental health. Within 
the systematic review, there was insufficient literature to assess potential moderators 
such as parent mental health. For the empirical paper, whilst the inclusion of a child 
anxiety measure, as well as allowing two parents to respond, was considered, it was 
not thought to be feasible. Including a child anxiety measure within the online design 
would have been complex, as appropriate measures are dependent on the age of the 
child, and no appropriate measure is available for very young children (Carpenter et 
al., 2016), and therefore would not have been relevant for all participants. Allowing 
multiple respondents (e.g. mother, father, child) more generally relies on a 
mechanism to group responses together, and would therefore be more feasible in a 
solely clinic based study. However, within the timeframe available for the thesis, 
online recruitment was considered necessary to allow sufficient recruitment to 
answer the primary research questions. As such, whilst future research would benefit 
from considering the psychological wellbeing of multiple family members, the 
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approach taken in the portfolio is considered to be the most appropriate within the 
scope of the thesis. 
 A further limitation of the online design was the reliance of parent reported 
food allergy and allergy severity, as it was not possible to obtain medical opinions. 
Whilst parent perception of severity or risk associated with health conditions has 
been found to be a more consistent predictive of poorer psychological outcomes than 
medical opinion (Price et al., 2016), it would be theoretically interesting and 
clinically useful to be able to compare parent and clinician ratings. In particular, for 
healthcare professionals working in food allergy, any risk factors based on medical 
information would be easier to screen for, as they would not typically involve 
gathering additional information. Alternatively, if there was low consensus between 
parent and medic opinions, this may highlight the importance of checking parents 
understanding of their child’s allergy, as this could have both psychological and 
medical implications. 
Both the empirical paper and systematic review were also limited to cross-
sectional designs, which are not equipped for establishing causality. Furthermore, it 
was not possible to control for factors such as time since most recent allergic 
reaction, or significant life transitions (such as children starting or changing schools). 
These factors may reasonably impact on anxiety directly and indirectly (e.g. parents 
with higher intolerance of uncertainty may find it more difficult to transfer 
responsibility to new adults or the child themselves). This could also help to explain 
why no significant relationship was found between time since allergy diagnosis and 
psychological outcomes within the exploratory analysis, despite reports that the 
psychological impact of food allergies improves with time (Cummings, Knibb, King, 
& Lucas, 2010).  
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Another possible limitation of the empirical paper, which it was not possible to 
control for, is the wider context in which recruitment occurred. During the 
recruitment phase of the research, food allergy received substantial interest in the 
general media, being the focus of numerous news reports (e.g. BBC, 2018; Davies, 
2018; Saner, 2018) and television programmes (e.g. Raddings, 2018). Unfortunately, 
this increased media attention primarily followed the death of teenagers with food 
allergy. Whilst a raised public awareness of food allergy may have a positive impact 
for the wider social support parents receive with managing their child’s food allergy, 
hearing of the worst case allergy scenario may also reasonably be anxiety provoking 
for parents. It would be interesting to explore the impact that this focus on food 
allergy is having for parents, particularly given the current review and consultation 
of food allergen labeling laws occurring in the UK (Department for Environmental 
Food & Rural Affairs, 2019). While these factors were not a direct focus of the 
portfolio, and more generally quantitative research is often not the most appropriate 
design for considering experiences of this type of event, all research is situated in a 
particular context.  This was part of the rationale for limiting recruitment to the UK, 
despite the online methodology, as awareness and laws surrounding food allergy 
differ nationally, and the research aimed to be applicable to the UK healthcare 
context. Any notable changes in this wider context are therefore important to 
consider in the interpretation of the results.  
 
Future Research 
While some suggestions of theoretical and clinical implications arising from the 
portfolio can and have been made, as the field is in its relative infancy arguably the 
strongest impact the present portfolio can have is in offering guidance for future 
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research. Many of these suggestions have been presented throughout the portfolio, 
notably the need for further (ideally longitudinal) research assessing PTSS in food 
allergy, the potential benefit of research refining measures assessing food allergy 
specific anxiety, and the need for a larger clinic based study more suitable for 
assessing prevalence and considering the perspectives of different family members. 
The following section will therefore focus on some additional suggestions arising 
from the portfolio. 
Firstly, although all the regression models presented in the empirical paper 
and exploratory analysis were significantly predictive of psychological outcomes, a 
large proportion of variance remains unexplained. Whilst this is not surprising, it 
does warrant consideration of additional factors that may be beneficial to consider in 
future research. One notable area that was not included in the present study is social 
factors.  
Social support has been reported as an important factor in paediatric PTSS 
literature (e.g. Young et al., 2003) and is included in Price et al.'s (2016) model of 
pediatric medical traumatic stress.  As previously identified, food allergy 
management is typically particularly reliant on other individuals, both closely (e.g. 
those to whom parents delegate caring responsibility) and more distantly (e.g. those 
involved in food production and labeling), it may therefore be expected that social 
factors could have a significant impact within this population. In past research, many 
parents of children with food allergy describe experiencing significant social 
negativity, for example others not taking the allergy seriously (e.g. Mandell et al., 
2005; Williams & Hankey, 2015), which could reasonably be a source of anxiety for 
parents. Both social support and social negativity have also been found to be 
significantly related to health related quality of life in parents of children with food 
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allergy (Williams & Hankey, 2015). Therefore, it could be beneficial for future 
research exploring mental health outcomes in food allergy to include an assessment 
of these social factors. 
Given the results of the meta-analysis, it may also be beneficial for future 
research to give greater consideration to depression in both children with food 
allergy and their parents. As demonstrated by the systematic review, there is 
currently a larger volume of research considering anxiety in this population; 
however, whilst heterogeneous, the results tentatively indicate a larger effect for 
depression in children with food allergy compared to their peers. Although not 
synthesized systematically, there also appears to be a smaller volume of research 
assessing parental depression compared to anxiety. A decision was made not to 
include a depression measure in the empirical paper, to minimize participant burden 
and due to greater theoretical differences in predictors that could warrant exploration. 
However, it may be useful for future research to expand on this. In particular, the 
social factors outlined above, especially social negativity, may be expected to impact 
on mood (Bertera, 2005). For children, the indications of increased incidence of 
bullying (Muraro et al., 2014) could also be expected to elevate rates of depression. 
Additionally, some parents may experience self-criticism or guilt following an 
allergic reaction (Gupta et al., 2008), which could be expected to impact on mood 
(e.g. Castilho, Pinto-Gouveia, & Duarte, 2017), as well as showing associations with 
PTSS in paediatric literature (e.g. Hawkins et al., 2019). Overall, the consideration of 
depression, alongside furthering the anxiety and PTSS literature, could allow a more 
comprehensive understanding of the psychological impact of paediatric food allergy. 
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Conclusion 
 This portfolio aimed to offer a timely and valuable contribution to the 
literature evaluating the psychological impact of food allergy for children and their 
parents. A systematic review of mental health in children with food allergy was 
conducted, providing indications of increased separation anxiety, generalized 
anxiety, and depression, but not social anxiety compared to their peers without food 
allergy. However, this review was limited by the high degree of heterogeneity in the 
current evidence base. 
 An original piece of empirical research was then presented considering the 
psychological impact for parents of children with food allergy. Notably, despite 
relatively longstanding suggestions of the need to assess post-traumatic stress in this 
population (e.g. Kelsay, 2003), this was the first study to do so using a validated 
trauma measure, providing useful and novel findings. The study found relatively 
high rates of anxiety (39.0%), worry (81.0%), and PTSS (42.3%) in a relatively large 
(N=104-105) sample of parents. These outcomes were consistently predicted by 
intolerance of uncertainty, with less consistent results for allergy severity and food 
allergy self-efficacy. 
 Overall, the portfolio highlights the need for greater awareness of the 
potential impact of food allergy on mental health. Whilst the portfolio is not without 
limitation, it offers an important contribution to the field, through both novel findings 
and offering direction for future research. 
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Appendix B: Forest Plots for all Meta-Analysis Syntheses 
 
 
Review Question 1: Prevalence 
 
 
Figure 5. Forest plot of non-disorder specific anxiety (prevalence). 	
 
 
Figure 6. Forest plot of social anxiety (prevalence). 
 
 
Figure 7. Forest plot of separation anxiety (prevalence) 
 
 	
		
Figure 8. Forest plot of generalized anxiety/ worry (prevalence). 
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Figure 9. Forest plot of depression (prevalence). 
 
 
 
Review Question 2: Difference 
 
 
 
 
Figure 10. Forest plot of non-disorder specific anxiety (difference). 
 
 
 
 
Figure 11. Forest plot of social anxiety (difference). 
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Figure 12. Forest plot of separation anxiety (difference). 
 
 
Figure 13. Forest plot of generalized anxiety/worry (difference). 
 
 
Figure 14. Forest plot of panic (difference). 
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Figure 15. Forest plot of depression (difference). 
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Publication Manual of the American Psychological Association (6th ed.). There are two exceptions: 
The academic degrees of authors should be placed on the title page following their names, and a 
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Key words should be included, consistent with APA style. Submissions should be double-spaced 
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study by the appropriate Institutional Review Board(s). Authors will also be asked to sign a statement, 
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the concept of "people first, not their disability." Terminology should reflect the "person with a 
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rather than the condition as an adjective (e.g., diabetic children, HIV patients, cancer families). 
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Special	Instructions	for	Types	of	Manuscripts	
Manuscript types include: 
• Original	research	
• Review	articles	
• Topical	reviews	
• Systematic	reviews	
• Invited	commentaries	
Original	Research	
Randomized controlled trials: JPP is committed to enhancing the transparent reporting of all 
intervention studies. (1) All Randomized Controlled Trials (RCTs) must be registered at or before the 
time of first patient enrollment in any primary registry of the WHO International Clinical Trials 
Registry Platform (ICTRP) or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP. 
Provide the registry name and registry number in the cover letter and methods section. (2) You are 
required to submit the CONSORT checklist and a flowchart of your research showing the steps found 
in the Consort E-Flowchart on this checklist for RCTs. You can use CONSORT checklist extensions 
for different designs and types of data beyond two group parallel trials. Please clearly indicate the 
page numbers where each checklist item is reported in the manuscript. Please upload this checklist as 
supplementary material when you submit your manuscript for consideration. Meeting these basic 
reporting requirements will greatly improve the value of your trial report and may enhance its chances 
for eventual publication. (3) If you are submitting a secondary data analysis from an RCT, please 
clearly indicate that it is a secondary data analysis in your manuscript and refer readers to the primary 
publication of outcomes. Consult with the editorial office if there are questions about reporting.  	
Non-randomized	trials:	If	you	are	submitting	a	non-randomized	trial	to	JPP,	you	are	required	to	follow	the	reporting	elements	of	the	TREND	statement	and	to	use	this	checklist	for	non-randomized	trials.	Please	clearly	indicate	the	page	numbers	where	each	checklist	item	is	reported	in	the	manuscript.	Please	upload	this	checklist	as	supplementary	material	when	you	submit	your	manuscript	for	consideration.		
 
All intervention studies (RCTs and non-randomized trials) will undergo an additional review for 
transparent reporting conducted by the JPP Assistant Editor for Transparent Reporting. Review 
comments will be provided on the corresponding checklist. Authors will be required to address any 
identified reporting issues prior to publication. 
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Authors are also encouraged to visit the Equator Network for additional information on transparent 
reporting of all manuscript types. 
(2) Single Subject Studies: As a journal that encourages submission of intervention studies, the Journal 
does accept, and encourages submission of, well-conducted single subject studies (N-of-1 designs). 
Case studies and narrative reports of special cases that are more descriptive will not be considered for 
review. It is important to note that rigorous single subject designs are considered logical equivalents 
of Randomized Controlled Trials and include control conditions that support conclusions of causality. 
Previously published examples can be found in this journal including: Bernard, Cohen, & Moffett 
(2009); Powers et al. (2006). Authors considering submissions of case reports adopting N-of-1 
methodology should consult the following sources within this journal: Cohen, Feinstein, Masuda, & 
Vowles (2014); Cushing, Walters, & Hoffman (2014); Rapoff & Stark (2008); Case reports that adopt 
formal N-of-1 methodology should not exceed 20 pages. 
References: 
Bernard, R. S., Cohen, L. L., & Moffett, K. (2009). A token economy for exercise adherence in 
pediatric cystic fibrosis: A single-subject analysis. Journal of Pediatric Psychology, 34, 354-365. 
Cohen, L. L., Feinstein, A., Masuda, A., & Vowles, K. E. (2014). Single-case research design in 
pediatric psychology: Considerations regarding data analysis. Journal of Pediatric Psychology, 39, 
124-137. 
Cushing, C. C., Walters, R. W., & Hoffman, L. (2014). Aggregated N-of-1 randomized controlled 
trials: Modern data analytics applied to a clinically valid method of intervention effectiveness. Journal 
of Pediatric Psychology, 39, 138-150. 
Powers, S. W., Piazza-Waggoner, C., Jones, J. S., Ferguson, K. S., Daines, C., & Acton, J. D. (2006). 
Examining clinical trial results with single-subject analysis: An example involving behavioral and 
nutrition treatment for young children with cystic fibrosis. Journal of Pediatric Psychology, 31, 574-
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Rapoff, M., & Stark, L. (2008). Editorial: Journal of Pediatric Psychology statement of purpose: 
Section on single-subject studies. Journal of Pediatric Psychology, 33, 16-21. 
(3) Measurement development and validation articles: For additional guidance please read, Holmbeck, 
G. & Devine, K. (2009) Editorial: An Author’s Checklist for Measure Development and Validation 
Manuscripts. 
(4) Historical Analysis in Pediatric Psychology: This is a special series of papers devoted to the 
history of pediatric psychology. Authors interested in submitting a paper for this series should contact 
the Editor of JPP to discuss potential papers prior to submission. There is no deadline for these papers 
(they may be submitted anytime). All submissions will be peer reviewed and should comply fully with 
the JPP Instructions to Authors. Papers in this series should be tightly focused contributions that 
expand our understanding of the roots, evolution, and/or impact of pediatric psychology as a 
discipline. Manuscripts may focus on the influence of individuals, published works, organizations, 
conceptualizations, philosophies or approaches, or clinical and professional activities. Successful 
papers should articulate a clear purpose/question and develop a compelling argument for the topic. 
Contributions should include a breadth of coverage, such that contradictory data are included and 
potential biases acknowledged. Historical analysis is more than a recounting of the “facts” and should 
include a thoughtful and scholarly interpretation of the subject matter. Papers should rely on primary 
sources and must be clearly and appropriately referenced. Supplemental materials to accompany the 
article may be posted online. 
Review	articles:	
(a) Topical reviews: Topical reviews summarize contemporary findings, suggest new conceptual 
models, or highlight noteworthy or controversial issues in pediatric psychology. Topical reviews are 
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limited to 2,000 words, contain no more than 2 tables or figures, and have an upper limit of 30 
references. Supplementary online material (e.g., additional tables) may be considered on a case by 
case basis. 
(b) Systematic reviews: Systematic reviews should not exceed 30 pages. Authors are required to 
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Authors can find the PRISMA checklist and flow diagram in downloadable templates that can be re-
used here. Authors of systematic reviews that do not include a meta-analysis must provide a clear 
justification in the manuscript explaining why such an analysis is not included for all or relevant 
portions of the report. 
Please consult this editorial (New Guidelines for Publishing Review Articles in JPP) which further 
describes guidelines for review articles, and the Checklist for Preparing and Evaluating Review 
Articles. 
Invited	commentaries	
• Commentaries	are	invited	on	all	topics	of	interest	in	pediatric	psychology,	and	the	page	length	and	scope	should	be	discussed	with	the	Editor.	Un-invited	commentaries	will	not	be	considered.	
Additional	Guidance	
The following links provide additional guidance for authors and reviewers: Editorial Policy, Authors’ 
Checklist, Guidelines for Reviews, Suggestions for Mentored Reviews, "People First," NIH policy, 
Replication of research, Duplicate and redundant policies, Conflict of interest. 
See the following articles for detailed guidance concerning preparation of manuscripts: Editorial: 
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Appendix E: Participant Information Sheet (Clinic Version) 
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Appendix F: Consent to Contact Form 
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Appendix G: Participant Information Sheet (Online) 
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Appendix H: Consent Form 
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Appendix I: Participant Pre-Brief 
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Appendix J: Participant Debrief Information 
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Appendix K: Demographic and Allergy Questionnaire 
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Appendix L: Penn State Worry Questionnaire (Meyer, Miller, Metzger, & 
Borkovec, 1990) 
 
 
Instructions: Rate each of the following statements on a scale of 1 (“not at all typical of me”) 
to 5 (“very typical of me”). Please do not leave any items blank.  	
 
Not at all typical                                     Very typical                      
of me                                                           of me  
1. If I do not have enough time to do everything, 
I do not worry about it.        1              2              3               4                5  
2. My worries overwhelm me.        1              2              3               4                5  
3. I do not tend to worry about things.        1              2              3               4                5  
4. Many situations make me worry.        1              2              3               4                5  
5. I know I should not worry about things, but I 
just cannot help it.  
      1              2              3               4                5  
6. When I am under pressure I worry a lot.        1              2              3               4                5  
7. I am always worrying about something.        1              2              3               4                5  
8. I find it easy to dismiss worrisome thoughts.        1              2              3               4                5  
9. As soon as I finish one task, I start to worry 
about everything else I have to do.  
      1              2              3               4                5  
10. I never worry about anything.        1              2              3               4                5  
11. When there is nothing more I can do about a 
concern, I do not worry about it any more.  
      1              2              3               4                5  
12. I have been a worrier all my life.        1              2              3               4                5  
13. I notice that I have been worrying about 
things.  
      1              2              3               4                5  
14. Once I start worrying, I cannot stop.        1              2              3               4                5  
15. I worry all the time.        1              2              3               4                5  
16. I worry about projects until they are all done.        1              2              3               4                5  		
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Appendix M: Depression Anxiety Stress Scales 21 - Anxiety subscale (Lovibond 
& Lovibond, 1995) 
 
 
Please read each statement and select a number 0, 1, 2 or 3 which indicated how 
much the statement applied to you over the past week. There are no right or wrong 
answers. Do not spend too much time on any statement. 
 
The rating scale is as follows: 
0 Did not apply to me at all 
1 Applied to me to some degree, or some of the time 
2 Applied to me to a considerable degree, or a good part of time 
3 Applied to me very much, or most of the time 
 
  
1 I was aware of dryness of my mouth 0      1      2      3 
2 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
3 I experienced trembling (eg, in the hands) 0      1      2      3 
4 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
5 I felt I was close to panic 0      1      2      3 
6 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
7 I felt scared without any good reason 0      1      2      3 	
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Appendix N: Impact of Events Scale – Revised (Weiss & Marmar, 1997) with 
Adapted Instructions 
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Appendix O: Intolerance of Uncertainty Scale – Short Form (Carleton et al., 
2007) 
 
 
 
Please circle the number that best corresponds to how much you agree with each item 
 
Not at all 
characteristic of 
me 
A little 
characteristic of 
me 
Somewhat 
characteristic of 
me 
Very 
characteristic of 
me 
Entirely 
characteristic of 
me 
1. Unforeseen events upset 
me greatly. 
1 2 3 4 5 
2. It frustrates me not having 
all the information I need. 
1 2 3 4 5 
3. Uncertainty keeps me from 
living a full life. 
1 2 3 4 5 
4. One should always look 
ahead so as to avoid 
surprises. 
1 2 3 4 5 
5. A small unforeseen event 
can spoil everything, even 
with the best of planning. 
1 2 3 4 5 
6. When it’s time to act, 
uncertainty paralyses me. 
1 2 3 4 5 
7. When I am uncertain I can’t 
function very well. 
1 2 3 4 5 
8. I always want to know what 
the future has in store for 
me. 
1 2 3 4 5 
9. I can’t stand being taken by 
surprise. 
1 2 3 4 5 
10. The smallest doubt can 
stop me from acting. 
1 2 3 4 5 
11. I should be able to 
organize everything in 
advance. 
1 2 3 4 5 
12. I must get away from all 
uncertain situations. 
1 2 3 4 5 
 
 
 
 
